,date,title,url
0,2000-03-30,浙江医药年报,/disclosure/listedinfo/announcement/c/600216_1999_0.pdf
1,2000-08-15,浙江医药半年报,/disclosure/listedinfo/announcement/c/600216_2000_1.pdf
2,2001-04-14,浙江医药年报,/disclosure/listedinfo/announcement/c/600216_2000_0.pdf
3,2001-05-30,浙江医药上市公司章程,/disclosure/listedinfo/announcement/c/600216_2001_g.pdf
4,2001-08-07,浙江医药半年报,/disclosure/listedinfo/announcement/c/600216_2001_1.pdf
5,2002-04-11,浙江医药治理纲要,/disclosure/listedinfo/announcement/c/600216_20020411_1.pdf
6,2002-04-11,浙江医药章程修改议案,/disclosure/listedinfo/announcement/c/600216_20020411_2.pdf
7,2002-04-11,浙江医药信息披露管理办法,/disclosure/listedinfo/announcement/c/600216_20020411_3.pdf
8,2002-04-11,浙江医药年报,/disclosure/listedinfo/announcement/c/600216_2001_n.pdf
9,2002-04-11,浙江医药内部控制制度,/disclosure/listedinfo/announcement/c/600216_20020411_7.pdf
10,2002-04-11,浙江医药股东大会议事规则,/disclosure/listedinfo/announcement/c/600216_20020411_4.pdf
11,2002-04-11,浙江医药独立董事工作制度,/disclosure/listedinfo/announcement/c/600216_20020411_5.pdf
12,2002-04-11,浙江医药董事会秘书工作条例,/disclosure/listedinfo/announcement/c/600216_20020411_6.pdf
13,2002-04-26,浙江医药第一季度季报,/disclosure/listedinfo/announcement/c/600216_2002_1.pdf
14,2002-05-31,浙江医药上市公司章程,/disclosure/listedinfo/announcement/c/600216_20020531_g.pdf
15,2002-06-27,浙江医药股东大会会议资料,/disclosure/listedinfo/announcement/c/600216_20020627_1.pdf
16,2002-08-10,浙江医药半年报,/disclosure/listedinfo/announcement/c/2002-08-10/600216_2002_z.pdf
17,2002-10-25,浙江医药第三季度季报,/disclosure/listedinfo/announcement/c/2002-10-25/600216_2002_3.pdf
18,2003-03-27,浙江医药年报,/disclosure/listedinfo/announcement/c/2003-03-27/600216_2002_n.pdf
19,2003-04-25,浙江医药第一季度季报,/disclosure/listedinfo/announcement/c/2003-04-25/600216_2003_1.pdf
20,2003-06-26,浙江医药股东大会会议资料,/disclosure/listedinfo/announcement/c/2003-06-26/600216_20030626_2.pdf
21,2003-06-26,浙江医药董事会专门委员会实施细则,/disclosure/listedinfo/announcement/c/2003-06-26/600216_20030626_1.pdf
22,2003-08-08,浙江医药上市公司章程,/disclosure/listedinfo/announcement/c/2003-08-08/600216_20030808_g.pdf
23,2003-08-28,浙江医药经理人员年薪制方案,/disclosure/listedinfo/announcement/c/2003-08-28/600216_20030828_1.pdf
24,2003-08-28,浙江医药半年报,/disclosure/listedinfo/announcement/c/2003-08-28/600216_2003_z.pdf
25,2003-10-28,浙江医药第三季度季报,/disclosure/listedinfo/announcement/c/2003-10-28/600216_2003_3.pdf
26,2003-12-31,浙江医药提供担保公告,/disclosure/listedinfo/announcement/c/2003-12-31/600216_20031231_2.pdf
27,2003-12-31,浙江医药董事会决议公告,/disclosure/listedinfo/announcement/c/2003-12-31/600216_20031231_1.pdf
28,2004-03-27,浙江医药年报,/disclosure/listedinfo/announcement/c/2004-03-27/600216_2003_n.pdf
29,2004-03-27,浙江医药监事会决议公告,/disclosure/listedinfo/announcement/c/2004-03-27/600216_20040327_2.pdf
30,2004-03-27,浙江医药董事会决议公告暨召开2003年度股东大会通知,/disclosure/listedinfo/announcement/c/2004-03-27/600216_20040327_1.pdf
31,2004-04-27,浙江医药第一季度季报,/disclosure/listedinfo/announcement/c/2004-04-27/600216_2004_1.pdf
32,2004-05-11,浙江医药2003年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2004-05-11/600216_20040511_1.pdf
33,2004-05-13,浙江医药2003年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2004-05-13/600216_20040513_1.pdf
34,2004-05-13,浙江医药2003年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2004-05-13/600216_20040513_2.pdf
35,2004-05-20,浙江医药上市公司章程,/disclosure/listedinfo/announcement/c/2004-05-20/600216_20040520_g.pdf
36,2004-06-21,浙江医药2003年度分红派息实施公告,/disclosure/listedinfo/announcement/c/2004-06-21/600216_20040621_1.pdf
37,2004-08-26,浙江医药继续与“康恩贝”互相担保的公告,/disclosure/listedinfo/announcement/c/2004-08-26/600216_20040826_2.pdf
38,2004-08-26,浙江医药董事会决议公告,/disclosure/listedinfo/announcement/c/2004-08-26/600216_20040826_1.pdf
39,2004-08-26,浙江医药半年报摘要,/disclosure/listedinfo/announcement/c/2004-08-26/600216_2004_zzy.pdf
40,2004-08-26,浙江医药半年报,/disclosure/listedinfo/announcement/c/2004-08-26/600216_2004_z.pdf
41,2004-09-28,浙江医药五产品进入“医保目录”的提示性公告,/disclosure/listedinfo/announcement/c/2004-09-28/600216_20040928_1.pdf
42,2004-10-12,浙江医药第二大股东终止《浙江医药股份有限公司股份转让合同》的公告,/disclosure/listedinfo/announcement/c/2004-10-12/600216_20041012_1.pdf
43,2004-10-27,浙江医药第三季度季报,/disclosure/listedinfo/announcement/c/2004-10-27/600216_2004_3.pdf
44,2004-12-21,浙江医药签定重大合同公告,/disclosure/listedinfo/announcement/c/2004-12-21/600216_20041221_1.pdf
45,2004-12-29,浙江医药为“浙大网新”提供担保的公告,/disclosure/listedinfo/announcement/c/2004-12-29/600216_20041229_2.pdf
46,2004-12-29,浙江医药监事会决议公告,/disclosure/listedinfo/announcement/c/2004-12-29/600216_20041229_3.pdf
47,2004-12-29,浙江医药董事会决议公告,/disclosure/listedinfo/announcement/c/2004-12-29/600216_20041229_1.pdf
48,2005-04-08,浙江医药澄清公告,/disclosure/listedinfo/announcement/c/2005-04-08/600216_20050408_1.pdf
49,2005-04-23,浙江医药与“来益生物”互保和继续与“升华控股”互保的公告,/disclosure/listedinfo/announcement/c/2005-04-23/600216_20050423_2.pdf
50,2005-04-23,浙江医药年报摘要,/disclosure/listedinfo/announcement/c/2005-04-23/600216_2004_nzy.pdf
51,2005-04-23,浙江医药年报,/disclosure/listedinfo/announcement/c/2005-04-23/600216_2004_n.pdf
52,2005-04-23,浙江医药监事会决议公告,/disclosure/listedinfo/announcement/c/2005-04-23/600216_20050423_3.pdf
53,2005-04-23,浙江医药董事会议事规则,/disclosure/listedinfo/announcement/c/2005-04-23/600216_20050423_4.pdf
54,2005-04-23,浙江医药董事会决议暨召开2004年度股东大会公告,/disclosure/listedinfo/announcement/c/2005-04-23/600216_20050423_1.pdf
55,2005-04-23,浙江医药第一季度季报,/disclosure/listedinfo/announcement/c/2005-04-23/600216_2005_1.pdf
56,2005-05-19,浙江医药为新昌国邦化学有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2005-05-19/600216_20050519_1.pdf
57,2005-06-03,浙江医药关于转让上海来益房地产开发有限公司股权及债权的临时董事会决议公告,/disclosure/listedinfo/announcement/c/2005-06-03/600216_20050603_1.pdf
58,2005-06-03,浙江医药2004年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2005-06-03/600216_20050603_2.pdf
59,2005-06-03,浙江医药2004年度股东大会法律意见书,/disclosure/listedinfo/announcement/c/2005-06-03/600216_20050603_3.pdf
60,2005-07-13,浙江医药关于转让浙江中强医药有限公司股权及债权的公告,/disclosure/listedinfo/announcement/c/2005-07-13/600216_20050713_2.pdf
61,2005-07-13,浙江医药关于转让上海来益房地产开发有限公司股权及债权的公告,/disclosure/listedinfo/announcement/c/2005-07-13/600216_20050713_1.pdf
62,2005-07-13,浙江医药2004年半年度业绩预增提示性公告,/disclosure/listedinfo/announcement/c/2005-07-13/600216_20050713_3.pdf
63,2005-07-26,浙江医药关于本芴醇生产车间顺利通过澳大利亚药品管理局现场检查的公告,/disclosure/listedinfo/announcement/c/2005-07-26/600216_20050726_1.pdf
64,2005-08-05,浙江医药信息披露管理办法,/disclosure/listedinfo/announcement/c/2005-08-05/600216_20050805_3.pdf
65,2005-08-05,浙江医药为康恩贝集团有限公司提供担保的公告,/disclosure/listedinfo/announcement/c/2005-08-05/600216_20050805_2.pdf
66,2005-08-05,浙江医药董事会决议公告,/disclosure/listedinfo/announcement/c/2005-08-05/600216_20050805_1.pdf
67,2005-08-05,浙江医药半年报摘要,/disclosure/listedinfo/announcement/c/2005-08-05/600216_2005_zzy.pdf
68,2005-08-05,浙江医药半年报,/disclosure/listedinfo/announcement/c/2005-08-05/600216_2005_z.pdf
69,2005-10-26,浙江医药业绩预增公告,/disclosure/listedinfo/announcement/c/2005-10-26/600216_20051026_1.pdf
70,2005-10-26,浙江医药第三季度季报,/disclosure/listedinfo/announcement/c/2005-10-26/600216_2005_3.pdf
71,2005-12-31,浙江医药核销有关资产的决议公告,/disclosure/listedinfo/announcement/c/2005-12-31/600216_20051231_1.pdf
72,2006-01-21,浙江医药关于控股股东所持股份性质变更的提示性公告,/disclosure/listedinfo/announcement/c/2006-01-21/600216_20060121_1.pdf
73,2006-01-23,浙江医药关于召开股权分置改革相关股东会议的通知,/disclosure/listedinfo/announcement/c/2006-01-23/600216_20060123_1.pdf
74,2006-01-23,浙江医药关于进行股权分置改革网上投资者交流会的通知,/disclosure/listedinfo/announcement/c/2006-01-23/600216_20060123_2.pdf
75,2006-01-23,浙江医药关于股权分置改革的独立董事意见函,/disclosure/listedinfo/announcement/c/2006-01-23/600216_20060123_7.pdf
76,2006-01-23,浙江医药股权分置改革之保荐意见书,/disclosure/listedinfo/announcement/c/2006-01-23/600216_20060123_5.pdf
77,2006-01-23,浙江医药股权分置改革说明书（摘要）,/disclosure/listedinfo/announcement/c/2006-01-23/600216_20060123_4.pdf
78,2006-01-23,浙江医药股权分置改革说明书,/disclosure/listedinfo/announcement/c/2006-01-23/600216_20060123_3.pdf
79,2006-01-23,浙江医药股权分置改革的法律意见书,/disclosure/listedinfo/announcement/c/2006-01-23/600216_20060123_6.pdf
80,2006-01-23,浙江医药董事会投票委托征集函,/disclosure/listedinfo/announcement/c/2006-01-23/600216_20060123_8.pdf
81,2006-02-10,浙江医药关于召开股权分置改革相关股东会议的第一次提示性公告,/disclosure/listedinfo/announcement/c/2006-02-10/600216_20060210_2.pdf
82,2006-02-10,浙江医药关于股权分置改革方案沟通协商情况暨调整股权分置改革方案的公告,/disclosure/listedinfo/announcement/c/2006-02-10/600216_20060210_1.pdf
83,2006-02-10,浙江医药股权分置改革之补充保荐意见,/disclosure/listedinfo/announcement/c/2006-02-10/600216_20060210_5.pdf
84,2006-02-10,浙江医药股权分置改革说明书摘要（修订稿）,/disclosure/listedinfo/announcement/c/2006-02-10/600216_20060210_4.pdf
85,2006-02-10,浙江医药股权分置改革说明书（修订稿）,/disclosure/listedinfo/announcement/c/2006-02-10/600216_20060210_3.pdf
86,2006-02-10,浙江医药股权分置改革的补充法律意见书,/disclosure/listedinfo/announcement/c/2006-02-10/600216_20060210_6.pdf
87,2006-02-10,浙江医药独立董事关于股权分置改革方案调整的意见函,/disclosure/listedinfo/announcement/c/2006-02-10/600216_20060210_7.pdf
88,2006-02-20,浙江医药关于召开股权分置改革相关股东会议的第二次提示性公告,/disclosure/listedinfo/announcement/c/2006-02-20/600216_20060220_1.pdf
89,2006-02-21,浙江医药关于股权分置改革方案获国务院国有资产监督管理委员会批准的公告,/disclosure/listedinfo/announcement/c/2006-02-21/600216_20060221_1.pdf
90,2006-02-24,浙江医药关于股权分置改革相关股东会议表决结果的公告,/disclosure/listedinfo/announcement/c/2006-02-24/600216_20060224_1.pdf
91,2006-02-24,浙江医药A股市场相关股东会议的法律意见书,/disclosure/listedinfo/announcement/c/2006-02-24/600216_20060224_2.pdf
92,2006-03-03,浙江医药股权分置改革方案实施公告,/disclosure/listedinfo/announcement/c/2006-03-03/600216_20060303_1.pdf
93,2006-04-14,G浙医药董事会临时会议决议公告,/disclosure/listedinfo/announcement/c/2006-04-14/600216_20060414_1.pdf
94,2006-04-26,G浙医药年报摘要,/disclosure/listedinfo/announcement/c/2006-04-26/600216_2005_nzy.pdf
95,2006-04-26,G浙医药年报,/disclosure/listedinfo/announcement/c/2006-04-26/600216_2005_n.pdf
96,2006-04-26,G浙医药监事会决议公告,/disclosure/listedinfo/announcement/c/2006-04-26/600216_20060426_2.pdf
97,2006-04-26,G浙医药董事会决议公告,/disclosure/listedinfo/announcement/c/2006-04-26/600216_20060426_1.pdf
98,2006-04-26,G浙医药第一季度季报,/disclosure/listedinfo/announcement/c/2006-04-26/600216_2006_1.pdf
99,2006-04-26,G浙医药2005年度关联方占用资金情况的专项审计说明,/disclosure/listedinfo/announcement/c/2006-04-26/600216_20060426_3.pdf
100,2006-05-26,G浙医药监事会决议公告,/disclosure/listedinfo/announcement/c/2006-05-26/600216_20060526_2.pdf
101,2006-05-26,G浙医药董事会决议暨召开2005年度股东大会公告,/disclosure/listedinfo/announcement/c/2006-05-26/600216_20060526_1.pdf
102,2006-06-09,G浙医药关于办公地址变更的公告,/disclosure/listedinfo/announcement/c/2006-06-09/600216_20060609_2.pdf
103,2006-06-09,G浙医药第二大股东更名的公告,/disclosure/listedinfo/announcement/c/2006-06-09/600216_20060609_1.pdf
104,2006-06-15,G浙医药关于召开2005年年度股东大会的补充公告,/disclosure/listedinfo/announcement/c/2006-06-15/600216_20060615_1.pdf
105,2006-06-27,G浙医药监事会议事规则,/disclosure/listedinfo/announcement/c/2006-06-27/600216_20060627_5.pdf
106,2006-06-27,G浙医药关联交易决策规则,/disclosure/listedinfo/announcement/c/2006-06-27/600216_20060627_6.pdf
107,2006-06-27,G浙医药股东大会议事规则,/disclosure/listedinfo/announcement/c/2006-06-27/600216_20060627_3.pdf
108,2006-06-27,G浙医药公司章程（修订稿）,/disclosure/listedinfo/announcement/c/2006-06-27/600216_20060627_g.pdf
109,2006-06-27,G浙医药董事会议事规则,/disclosure/listedinfo/announcement/c/2006-06-27/600216_20060627_4.pdf
110,2006-06-27,G浙医药2005年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2006-06-27/600216_20060627_1.pdf
111,2006-06-27,G浙医药2005年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2006-06-27/600216_20060627_2.pdf
112,2006-06-28,G浙医药监事会决议公告,/disclosure/listedinfo/announcement/c/2006-06-28/600216_20060628_2.pdf
113,2006-06-28,G浙医药董事会决议公告,/disclosure/listedinfo/announcement/c/2006-06-28/600216_20060628_1.pdf
114,2006-08-18,G浙医药半年报摘要,/disclosure/listedinfo/announcement/c/2006-08-18/600216_2006_zzy.pdf
115,2006-08-18,G浙医药半年报,/disclosure/listedinfo/announcement/c/2006-08-18/600216_2006_z.pdf
116,2006-08-18,G浙医药2005年度分红派息实施公告,/disclosure/listedinfo/announcement/c/2006-08-18/600216_20060818_1.pdf
117,2006-10-09,浙江医药部分产品提高出口退税率的公告,/disclosure/listedinfo/announcement/c/2006-10-09/600216_20061009_1.pdf
118,2006-10-24,浙江医药第三季度季报,/disclosure/listedinfo/announcement/c/2006-10-24/600216_2006_3.pdf
119,2007-01-05,浙江医药关于核销有关资产的决议公告,/disclosure/listedinfo/announcement/c/2007-01-05/600216_20070105_1.pdf
120,2007-01-05,浙江医药关于成立枝江中昌生物科技有限公司的公告,/disclosure/listedinfo/announcement/c/2007-01-05/600216_20070105_2.pdf
121,2007-03-02,浙江医药有限售条件的流通股上市公告,/disclosure/listedinfo/announcement/c/2007-03-02/600216_20070302_1.pdf
122,2007-04-11,浙江医药年报摘要,/disclosure/listedinfo/announcement/c/2007-04-11/600216_2006_nzy.pdf
123,2007-04-11,浙江医药年报,/disclosure/listedinfo/announcement/c/2007-04-11/600216_2006_n.pdf
124,2007-04-11,浙江医药监事会决议公告,/disclosure/listedinfo/announcement/c/2007-04-11/600216_20070411_2.pdf
125,2007-04-11,浙江医药董事会决议公告,/disclosure/listedinfo/announcement/c/2007-04-11/600216_20070411_1.pdf
126,2007-04-11,浙江医药2006年度非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2007-04-11/600216_20070411_3.pdf
127,2007-04-14,浙江医药2007年第一季度业绩预减公告,/disclosure/listedinfo/announcement/c/2007-04-14/600216_20070414_1.pdf
128,2007-04-24,浙江医药监事会决议公告,/disclosure/listedinfo/announcement/c/2007-04-24/600216_20070424_2.pdf
129,2007-04-24,浙江医药董事会决议公告,/disclosure/listedinfo/announcement/c/2007-04-24/600216_20070424_1.pdf
130,2007-04-24,浙江医药第一季度季报,/disclosure/listedinfo/announcement/c/2007-04-24/600216_2007_1.pdf
131,2007-04-30,浙江医药关于召开2006年度股东大会的通知,/disclosure/listedinfo/announcement/c/2007-04-30/600216_20070430_1.pdf
132,2007-05-24,浙江医药2006年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2007-05-24/600216_20070524_1.pdf
133,2007-05-24,浙江医药2006年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2007-05-24/600216_20070524_3.pdf
134,2007-05-24,浙江医药2006年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2007-05-24/600216_20070524_2.pdf
135,2007-06-19,浙江医药关于产品价格变动情况说明公告,/disclosure/listedinfo/announcement/c/2007-06-19/600216_20070619_1.pdf
136,2007-06-29,浙江医药信息披露管理办法,/disclosure/listedinfo/announcement/c/2007-06-29/600216_20070629_3.pdf
137,2007-06-29,浙江医药关于加强上市公司治理专项活动的自查报告及整改计划,/disclosure/listedinfo/announcement/c/2007-06-29/600216_20070629_2.pdf
138,2007-06-29,浙江医药董事会决议公告,/disclosure/listedinfo/announcement/c/2007-06-29/600216_20070629_1.pdf
139,2007-07-13,浙江医药重大事项停牌公告,/disclosure/listedinfo/announcement/c/2007-07-13/600216_20070713_1.pdf
140,2007-07-17,浙江医药2006年度分红派息实施公告,/disclosure/listedinfo/announcement/c/2007-07-17/600216_20070717_1.pdf
141,2007-08-15,浙江医药签定重大合同公告,/disclosure/listedinfo/announcement/c/2007-08-15/600216_20070815_2.pdf
142,2007-08-15,浙江医药复牌公告,/disclosure/listedinfo/announcement/c/2007-08-15/600216_20070815_1.pdf
143,2007-08-17,浙江医药股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2007-08-17/600216_20070817_1.pdf
144,2007-08-27,浙江医药半年报摘要,/disclosure/listedinfo/announcement/c/2007-08-27/600216_2007_zzy.pdf
145,2007-08-27,浙江医药半年报,/disclosure/listedinfo/announcement/c/2007-08-27/600216_2007_z.pdf
146,2007-09-18,浙江医药股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2007-09-18/600216_20070918_1.pdf
147,2007-10-13,浙江医药董事会公告,/disclosure/listedinfo/announcement/c/2007-10-13/600216_20071013_1.pdf
148,2007-10-25,浙江医药治理整改报告,/disclosure/listedinfo/announcement/c/2007-10-25/600216_20071025_2.pdf
149,2007-10-25,浙江医药董事会决议公告,/disclosure/listedinfo/announcement/c/2007-10-25/600216_20071025_1.pdf
150,2007-10-25,浙江医药第三季度季报,/disclosure/listedinfo/announcement/c/2007-10-25/600216_2007_3.pdf
151,2007-10-31,浙江医药关于维生素H系列产品提价公告,/disclosure/listedinfo/announcement/c/2007-10-31/600216_20071031_1.pdf
152,2007-12-06,浙江医药关于盐酸万古霉素原料药获得美国FDA正式批准的公告,/disclosure/listedinfo/announcement/c/2007-12-06/600216_20071206_1.pdf
153,2007-12-25,浙江医药控股子公司管理制度,/disclosure/listedinfo/announcement/c/2007-12-25/600216_20071225_2.pdf
154,2007-12-25,浙江医药董事会决议公告,/disclosure/listedinfo/announcement/c/2007-12-25/600216_20071225_1.pdf
155,2008-02-22,浙江医药产品提价公告,/disclosure/listedinfo/announcement/c/2008-02-22/600216_20080222_1.pdf
156,2008-02-26,浙江医药股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2008-02-26/600216_20080226_1.pdf
157,2008-03-04,浙江医药有限售条件的流通股上市公告,/disclosure/listedinfo/announcement/c/2008-03-04/600216_20080304_1.pdf
158,2008-03-04,浙江医药关于更换公司股权分置改革持续督导保荐代表人的公告,/disclosure/listedinfo/announcement/c/2008-03-04/600216_20080304_2.pdf
159,2008-03-27,浙江医药临时公告,/disclosure/listedinfo/announcement/c/2008-03-27/600216_20080327_1.pdf
160,2008-04-15,浙江医药2008年一季度业绩预增公告,/disclosure/listedinfo/announcement/c/2008-04-15/600216_20080415_1.pdf
161,2008-04-23,浙江医药年报摘要,/disclosure/listedinfo/announcement/c/2008-04-23/600216_2007_nzy.pdf
162,2008-04-23,浙江医药年报,/disclosure/listedinfo/announcement/c/2008-04-23/600216_2007_n.pdf
163,2008-04-23,浙江医药监事会决议公告,/disclosure/listedinfo/announcement/c/2008-04-23/600216_20080423_2.pdf
164,2008-04-23,浙江医药关于召开2007年度股东大会的通知,/disclosure/listedinfo/announcement/c/2008-04-23/600216_20080423_3.pdf
165,2008-04-23,浙江医药独立董事年报工作制度,/disclosure/listedinfo/announcement/c/2008-04-23/600216_20080423_6.pdf
166,2008-04-23,浙江医药董事会审计委员会年度报告工作规程,/disclosure/listedinfo/announcement/c/2008-04-23/600216_20080423_5.pdf
167,2008-04-23,浙江医药董事会决议公告,/disclosure/listedinfo/announcement/c/2008-04-23/600216_20080423_1.pdf
168,2008-04-23,浙江医药第一季度季报,/disclosure/listedinfo/announcement/c/2008-04-23/600216_2008_1.pdf
169,2008-04-23,浙江医药2007年度非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2008-04-23/600216_20080423_4.pdf
170,2008-05-08,浙江医药重大合同公告,/disclosure/listedinfo/announcement/c/2008-05-08/600216_20080508_1.pdf
171,2008-05-23,浙江医药2007年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2008-05-23/600216_20080523_1.pdf
172,2008-05-23,浙江医药2007年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2008-05-23/600216_20080523_2.pdf
173,2008-05-31,浙江医药产品提价公告,/disclosure/listedinfo/announcement/c/2008-05-31/600216_20080531_1.pdf
174,2008-07-10,浙江医药2007年度分红派息实施公告,/disclosure/listedinfo/announcement/c/2008-07-10/600216_20080710_1.pdf
175,2008-07-17,浙江医药停牌公告,/disclosure/listedinfo/announcement/c/2008-07-17/600216_20080717_2.pdf
176,2008-07-17,浙江医药2008年上半年业绩预增公告,/disclosure/listedinfo/announcement/c/2008-07-17/600216_20080717_1.pdf
177,2008-07-18,浙江医药治理整改情况说明,/disclosure/listedinfo/announcement/c/2008-07-18/600216_20080718_4.pdf
178,2008-07-18,浙江医药首期股票期权激励计划（草案）,/disclosure/listedinfo/announcement/c/2008-07-18/600216_20080718_3.pdf
179,2008-07-18,浙江医药监事会决议公告,/disclosure/listedinfo/announcement/c/2008-07-18/600216_20080718_2.pdf
180,2008-07-18,浙江医药董事会决议公告,/disclosure/listedinfo/announcement/c/2008-07-18/600216_20080718_1.pdf
181,2008-08-20,浙江医药第四届十三次董事会决议公告,/disclosure/listedinfo/announcement/c/2008-08-20/600216_20080820_1.pdf
182,2008-08-20,浙江医药半年报摘要,/disclosure/listedinfo/announcement/c/2008-08-20/600216_2008_zzy.pdf
183,2008-08-20,浙江医药半年报,/disclosure/listedinfo/announcement/c/2008-08-20/600216_2008_z.pdf
184,2008-09-06,浙江医药有限售条件的流通股上市公告,/disclosure/listedinfo/announcement/c/2008-09-06/600216_20080906_1.pdf
185,2008-10-16,浙江医药关于本公司取得国家高新技术企业资格的公告,/disclosure/listedinfo/announcement/c/2008-10-16/600216_20081016_1.pdf
186,2008-10-16,浙江医药关于2008年度（1-9月）业绩预告的修正公告,/disclosure/listedinfo/announcement/c/2008-10-16/600216_20081016_2.pdf
187,2008-10-24,浙江医药关于2008年度业绩预增公告,/disclosure/listedinfo/announcement/c/2008-10-24/600216_20081024_1.pdf
188,2008-10-24,浙江医药第三季度季报,/disclosure/listedinfo/announcement/c/2008-10-24/600216_2008_3.pdf
189,2008-11-11,浙江医药四届十五次董事会决议公告,/disclosure/listedinfo/announcement/c/2008-11-11/600216_20081111_1.pdf
190,2008-11-18,浙江医药四届十六次董事会决议公告暨召开2008年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2008-11-18/600216_20081118_1.pdf
191,2008-11-28,浙江医药2008年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2008-11-28/600216_20081128_1.pdf
192,2008-12-04,浙江医药2008年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2008-12-04/600216_20081204_1.pdf
193,2008-12-04,浙江医药2008年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2008-12-04/600216_20081204_2.pdf
194,2008-12-10,浙江医药第四届十七次董事会决议公告,/disclosure/listedinfo/announcement/c/2008-12-10/600216_20081210_1.pdf
195,2008-12-16,浙江医药关于公司第一大股东股权质押公告,/disclosure/listedinfo/announcement/c/2008-12-16/600216_20081216_1.pdf
196,2008-12-30,浙江医药关于会计师事务所名称变更公告,/disclosure/listedinfo/announcement/c/2008-12-30/600216_20081230_1.pdf
197,2009-03-04,浙江医药有限售条件的流通股上市公告,/disclosure/listedinfo/announcement/c/2009-03-04/600216_20090304_1.pdf
198,2009-03-27,浙江医药四届十二次监事会决议公告,/disclosure/listedinfo/announcement/c/2009-03-27/600216_20090327_2.pdf
199,2009-03-27,浙江医药年报摘要,/disclosure/listedinfo/announcement/c/2009-03-27/600216_2008_nzy.pdf
200,2009-03-27,浙江医药年报,/disclosure/listedinfo/announcement/c/2009-03-27/600216_2008_n.pdf
201,2009-03-27,浙江医药董事会审计委员会年度报告工作规程,/disclosure/listedinfo/announcement/c/2009-03-27/600216_20090327_4.pdf
202,2009-03-27,浙江医药第四届十八次董事会决议公告,/disclosure/listedinfo/announcement/c/2009-03-27/600216_20090327_1.pdf
203,2009-03-27,浙江医药2008年度非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2009-03-27/600216_20090327_3.pdf
204,2009-04-02,浙江医药关于公司维生素类产品生产经营情况公告,/disclosure/listedinfo/announcement/c/2009-04-02/600216_20090402_1.pdf
205,2009-04-23,浙江医药第一季度季报,/disclosure/listedinfo/announcement/c/2009-04-23/600216_2009_1.pdf
206,2009-04-23,浙江医药第四届十九次董事会决议公告暨召开2008年度股东大会公告,/disclosure/listedinfo/announcement/c/2009-04-23/600216_20090423_1.pdf
207,2009-05-08,浙江医药2008年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-05-08/600216_20090508_1.pdf
208,2009-05-14,浙江医药2008年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-05-14/600216_20090514_1.pdf
209,2009-05-14,浙江医药2008年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2009-05-14/600216_20090514_2.pdf
210,2009-05-21,浙江医药2008年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2009-05-21/600216_20090521_1.pdf
211,2009-06-13,浙江医药第四届十四次监事会决议公告,/disclosure/listedinfo/announcement/c/2009-06-13/600216_20090613_2.pdf
212,2009-06-13,浙江医药第四届二十次董事会决议公告暨召开2009年度第一次临时股东大会公告,/disclosure/listedinfo/announcement/c/2009-06-13/600216_20090613_1.pdf
213,2009-06-24,浙江医药2009年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2009-06-24/600216_20090624_1.pdf
214,2009-06-30,浙江医药第五届一次监事会决议公告,/disclosure/listedinfo/announcement/c/2009-06-30/600216_20090630_3.pdf
215,2009-06-30,浙江医药第五届一次董事会决议公告,/disclosure/listedinfo/announcement/c/2009-06-30/600216_20090630_2.pdf
216,2009-06-30,浙江医药2009年度第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2009-06-30/600216_20090630_1.pdf
217,2009-06-30,浙江医药2009年度第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2009-06-30/600216_20090630_4.pdf
218,2009-07-16,浙江医药董事会讣告,/disclosure/listedinfo/announcement/c/2009-07-16/600216_20090716_1.pdf
219,2009-08-10,浙江医药股票交易异常波动公告,/disclosure/listedinfo/announcement/c/2009-08-10/600216_20090810_1.pdf
220,2009-08-25,浙江医药半年报摘要,/disclosure/listedinfo/announcement/c/2009-08-25/600216_2009_zzy.pdf
221,2009-08-25,浙江医药半年报,/disclosure/listedinfo/announcement/c/2009-08-25/600216_2009_z.pdf
222,2009-09-01,浙江医药关于公司第一大股东股权质押业务的公告,/disclosure/listedinfo/announcement/c/2009-09-01/600216_20090901_1.pdf
223,2009-10-10,浙江医药关于公司下属主要生产企业停产检修的公告,/disclosure/listedinfo/announcement/c/2009-10-10/600216_20091010_1.pdf
224,2009-10-28,浙江医药第三季度季报,/disclosure/listedinfo/announcement/c/2009-10-28/600216_2009_3.pdf
225,2009-12-02,浙江医药关于会计师事务所名称变更的公告,/disclosure/listedinfo/announcement/c/2009-12-02/600216_20091202_2.pdf
226,2009-12-02,浙江医药关于公司下属企业新昌制药厂被命名为“国家创新型企业”的公告,/disclosure/listedinfo/announcement/c/2009-12-02/600216_20091202_1.pdf
227,2009-12-18,浙江医药董事会公告,/disclosure/listedinfo/announcement/c/2009-12-18/600216_20091218_1.pdf
228,2009-12-29,浙江医药关于本公司参股公司浙江仙琚制药股份有限公司发行上市的公告,/disclosure/listedinfo/announcement/c/2009-12-29/600216_20091229_1.pdf
229,2010-01-06,浙江医药关于原料药本芴醇和蒿甲醚获得美国FDA正式批准的公告,/disclosure/listedinfo/announcement/c/2010-01-06/600216_20100106_1.pdf
230,2010-03-27,浙江医药五届四次监事会决议公告,/disclosure/listedinfo/announcement/c/2010-03-27/600216_20100327_2.pdf
231,2010-03-27,浙江医药外部信息使用人管理制度,/disclosure/listedinfo/announcement/c/2010-03-27/600216_20100327_6.pdf
232,2010-03-27,浙江医药突发事件处理制度,/disclosure/listedinfo/announcement/c/2010-03-27/600216_20100327_7.pdf
233,2010-03-27,浙江医药年报摘要,/disclosure/listedinfo/announcement/c/2010-03-27/600216_2009_nzy.pdf
234,2010-03-27,浙江医药年报信息披露重大差错责任追究制度,/disclosure/listedinfo/announcement/c/2010-03-27/600216_20100327_5.pdf
235,2010-03-27,浙江医药年报,/disclosure/listedinfo/announcement/c/2010-03-27/600216_2009_n.pdf
236,2010-03-27,浙江医药内幕信息知情人登记制度,/disclosure/listedinfo/announcement/c/2010-03-27/600216_20100327_4.pdf
237,2010-03-27,浙江医药第五届四次董事会决议公告暨召开2009年度股东大会公告,/disclosure/listedinfo/announcement/c/2010-03-27/600216_20100327_1.pdf
238,2010-03-27,浙江医药财务会计管理及内控制度,/disclosure/listedinfo/announcement/c/2010-03-27/600216_20100327_8.pdf
239,2010-03-27,浙江医药2009年度非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2010-03-27/600216_20100327_3.pdf
240,2010-04-08,浙江医药2010年第一季度业绩预增公告,/disclosure/listedinfo/announcement/c/2010-04-08/600216_20100408_1.pdf
241,2010-04-14,浙江医药2009年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2010-04-14/600216_20100414_1.pdf
242,2010-04-21,浙江医药2009年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2010-04-21/600216_20100421_1.pdf
243,2010-04-21,浙江医药2009年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2010-04-21/600216_20100421_2.pdf
244,2010-04-24,浙江医药董事、监事、高管人员持股及变动管理制度,/disclosure/listedinfo/announcement/c/2010-04-24/600216_20100424_2.pdf
245,2010-04-24,浙江医药第一季度季报,/disclosure/listedinfo/announcement/c/2010-04-24/600216_2010_1.pdf
246,2010-04-24,浙江医药第五届五次董事会决议公告,/disclosure/listedinfo/announcement/c/2010-04-24/600216_20100424_1.pdf
247,2010-04-28,浙江医药2009年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2010-04-28/600216_20100428_1.pdf
248,2010-08-24,浙江医药五届六次董事会决议公告,/disclosure/listedinfo/announcement/c/2010-08-24/600216_20100824_1.pdf
249,2010-08-24,浙江医药半年报摘要,/disclosure/listedinfo/announcement/c/2010-08-24/600216_2010_zzy.pdf
250,2010-08-24,浙江医药半年报,/disclosure/listedinfo/announcement/c/2010-08-24/600216_2010_z.pdf
251,2010-10-30,浙江医药第三季度季报,/disclosure/listedinfo/announcement/c/2010-10-30/600216_2010_3.pdf
252,2011-03-05,浙江医药2010年度业绩快报,/disclosure/listedinfo/announcement/c/2011-03-05/600216_20110305_1.pdf
253,2011-03-25,浙江医药五届八次董事会决议公告,/disclosure/listedinfo/announcement/c/2011-03-25/600216_20110325_1.pdf
254,2011-04-09,浙江医药五届八次监事会决议公告,/disclosure/listedinfo/announcement/c/2011-04-09/600216_20110409_2.pdf
255,2011-04-09,浙江医药年报摘要,/disclosure/listedinfo/announcement/c/2011-04-09/600216_2010_nzy.pdf
256,2011-04-09,浙江医药年报,/disclosure/listedinfo/announcement/c/2011-04-09/600216_2010_n.pdf
257,2011-04-09,浙江医药非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2011-04-09/600216_20110409_3.pdf
258,2011-04-09,浙江医药第五届九次董事会决议公告,/disclosure/listedinfo/announcement/c/2011-04-09/600216_20110409_1.pdf
259,2011-04-12,浙江医药公告,/disclosure/listedinfo/announcement/c/2011-04-12/600216_20110412_1.pdf
260,2011-04-20,浙江医药五届十次董事会决议公告,/disclosure/listedinfo/announcement/c/2011-04-20/600216_20110420_1.pdf
261,2011-04-30,浙江医药董事会秘书工作制度,/disclosure/listedinfo/announcement/c/2011-04-30/600216_20110430_2.pdf
262,2011-04-30,浙江医药第一季度季报,/disclosure/listedinfo/announcement/c/2011-04-30/600216_2011_1.pdf
263,2011-04-30,浙江医药第五届十一次董事会决议公告暨召开2010年度股东大会公告,/disclosure/listedinfo/announcement/c/2011-04-30/600216_20110430_1.pdf
264,2011-05-11,浙江医药公告,/disclosure/listedinfo/announcement/c/2011-05-11/600216_20110511_1.pdf
265,2011-05-21,浙江医药2010年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2011-05-21/600216_20110521_1.pdf
266,2011-05-28,浙江医药2010年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2011-05-28/600216_20110528_1.pdf
267,2011-05-28,浙江医药2010年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2011-05-28/600216_20110528_2.pdf
268,2011-06-07,浙江医药2010年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2011-06-07/600216_20110607_1.pdf
269,2011-06-17,浙江医药有限售条件的流通股上市公告,/disclosure/listedinfo/announcement/c/2011-06-17/600216_20110617_1.pdf
270,2011-06-27,浙江医药重大事项停牌公告,/disclosure/listedinfo/announcement/c/2011-06-27/600216_20110627_1.pdf
271,2011-07-04,浙江医药五届十次监事会决议公告,/disclosure/listedinfo/announcement/c/2011-07-04/600216_20110704_2.pdf
272,2011-07-04,浙江医药非公开发行股票预案,/disclosure/listedinfo/announcement/c/2011-07-04/600216_20110704_3.pdf
273,2011-07-04,浙江医药第五届十二次董事会决议公告,/disclosure/listedinfo/announcement/c/2011-07-04/600216_20110704_1.pdf
274,2011-07-07,浙江医药关于日本Kaneka公司向美国ITC申请对公司辅酶Q10产品进行337调查的公告,/disclosure/listedinfo/announcement/c/2011-07-07/600216_20110707_1.pdf
275,2011-07-07,浙江医药关于成立合资公司的公告,/disclosure/listedinfo/announcement/c/2011-07-07/600216_20110707_2.pdf
276,2011-07-22,浙江医药关于公司下属主要生产企业停产检修的公告,/disclosure/listedinfo/announcement/c/2011-07-22/600216_20110722_1.pdf
277,2011-08-25,浙江医药第五届十三次董事会决议公告暨召开2011年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2011-08-25/600216_20110825_1.pdf
278,2011-08-25,浙江医药半年报摘要,/disclosure/listedinfo/announcement/c/2011-08-25/600216_2011_zzy.pdf
279,2011-08-25,浙江医药半年报,/disclosure/listedinfo/announcement/c/2011-08-25/600216_2011_z.pdf
280,2011-09-01,浙江医药关于公司辅酶Q10产品涉诉事项最新进展公告,/disclosure/listedinfo/announcement/c/2011-09-01/600216_20110901_1.pdf
281,2011-09-14,浙江医药关于召开2011年第一次临时股东大会的二次通知,/disclosure/listedinfo/announcement/c/2011-09-14/600216_20110914_1.pdf
282,2011-09-14,浙江医药2011年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2011-09-14/600216_20110914_2.pdf
283,2011-09-21,浙江医药2011年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2011-09-21/600216_20110921_1.pdf
284,2011-09-21,浙江医药2011年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2011-09-21/600216_20110921_2.pdf
285,2011-10-27,浙江医药第五届十四次董事会决议公告,/disclosure/listedinfo/announcement/c/2011-10-27/600216_20111027_1.pdf
286,2011-10-27,浙江医药第三季度季报,/disclosure/listedinfo/announcement/c/2011-10-27/600216_2011_3.pdf
287,2011-12-23,浙江医药五届十五次董事会决议公告,/disclosure/listedinfo/announcement/c/2011-12-23/600216_20111223_1.pdf
288,2012-02-08,浙江医药关于下属全资子公司竞得土地使用权的公告,/disclosure/listedinfo/announcement/c/2012-02-08/600216_20120208_2.pdf
289,2012-02-08,浙江医药2011年度业绩快报,/disclosure/listedinfo/announcement/c/2012-02-08/600216_20120208_1.pdf
290,2012-02-10,浙江医药股东解除股权质押公告,/disclosure/listedinfo/announcement/c/2012-02-10/600216_20120210_1.pdf
291,2012-02-11,浙江医药非公开发行股票预案（修订稿）,/disclosure/listedinfo/announcement/c/2012-02-11/600216_20120211_2.pdf
292,2012-02-11,浙江医药第五届十六次董事会决议公告暨召开2012年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2012-02-11/600216_20120211_1.pdf
293,2012-02-16,浙江医药关于通过高新技术企业复审公告,/disclosure/listedinfo/announcement/c/2012-02-16/600216_20120216_1.pdf
294,2012-02-23,浙江医药2012年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-02-23/600216_20120223_2.pdf
295,2012-02-23,浙江医药2012年第一次临时股东大会的二次通知,/disclosure/listedinfo/announcement/c/2012-02-23/600216_20120223_1.pdf
296,2012-02-29,浙江医药2012年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-02-29/600216_20120229_1.pdf
297,2012-02-29,浙江医药2012年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2012-02-29/600216_20120229_2.pdf
298,2012-03-16,浙江医药关于公司辅酶Q10产品涉诉事项德国诉讼案最新进展公告,/disclosure/listedinfo/announcement/c/2012-03-16/600216_20120316_1.pdf
299,2012-03-31,浙江医药内部控制规范实施工作方案,/disclosure/listedinfo/announcement/c/2012-03-31/600216_20120331_3.pdf
300,2012-03-31,浙江医药关于为全资子公司提供担保的公告,/disclosure/listedinfo/announcement/c/2012-03-31/600216_20120331_2.pdf
301,2012-03-31,浙江医药第五届十七次董事会决议公告,/disclosure/listedinfo/announcement/c/2012-03-31/600216_20120331_1.pdf
302,2012-04-24,浙江医药五届十三次监事会决议公告,/disclosure/listedinfo/announcement/c/2012-04-24/600216_20120424_2.pdf
303,2012-04-24,浙江医药前次募集资金使用情况报告,/disclosure/listedinfo/announcement/c/2012-04-24/600216_20120424_3.pdf
304,2012-04-24,浙江医药年报摘要,/disclosure/listedinfo/announcement/c/2012-04-24/600216_2011_nzy.pdf
305,2012-04-24,浙江医药年报,/disclosure/listedinfo/announcement/c/2012-04-24/600216_2011_n.pdf
306,2012-04-24,浙江医药内幕信息知情人登记制度,/disclosure/listedinfo/announcement/c/2012-04-24/600216_20120424_6.pdf
307,2012-04-24,浙江医药非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2012-04-24/600216_20120424_4.pdf
308,2012-04-24,浙江医药第五届十八次董事会决议公告,/disclosure/listedinfo/announcement/c/2012-04-24/600216_20120424_1.pdf
309,2012-04-24,浙江医药2011年度独立董事工作报告,/disclosure/listedinfo/announcement/c/2012-04-24/600216_20120424_5.pdf
310,2012-04-26,浙江医药第一季度季报,/disclosure/listedinfo/announcement/c/2012-04-26/600216_2012_1.pdf
311,2012-05-08,浙江医药关于分红情况说明的公告,/disclosure/listedinfo/announcement/c/2012-05-08/600216_20120508_1.pdf
312,2012-05-22,浙江医药五届二十次董事会决议公告,/disclosure/listedinfo/announcement/c/2012-05-22/600216_20120522_1.pdf
313,2012-05-22,浙江医药关于非公开发行A股股票申请获得中国证监会发行审核委员会无条件审核通过的公告,/disclosure/listedinfo/announcement/c/2012-05-22/600216_20120522_2.pdf
314,2012-06-01,浙江医药第五届十五次监事会决议公告,/disclosure/listedinfo/announcement/c/2012-06-01/600216_20120601_2.pdf
315,2012-06-01,浙江医药第五届二十一次董事会决议公告暨召开2011年度股东大会公告,/disclosure/listedinfo/announcement/c/2012-06-01/600216_20120601_1.pdf
316,2012-06-12,浙江医药分红政策及未来三年股东回报规划,/disclosure/listedinfo/announcement/c/2012-06-12/600216_20120612_2.pdf
317,2012-06-12,浙江医药第五届二十二次董事会决议公告暨召开2012年第二次临时股东大会公告,/disclosure/listedinfo/announcement/c/2012-06-12/600216_20120612_1.pdf
318,2012-06-15,浙江医药2011年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-06-15/600216_20120615_1.pdf
319,2012-06-21,浙江医药2012年第二次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2012-06-21/600216_20120621_1.pdf
320,2012-06-25,浙江医药关于与太景生物科技股份有限公司及太景医药研发（北京）有限公司签署《技术授权及合作协议》的公告,/disclosure/listedinfo/announcement/c/2012-06-25/600216_20120625_4.pdf
321,2012-06-25,浙江医药第六届一次监事会决议公告,/disclosure/listedinfo/announcement/c/2012-06-25/600216_20120625_3.pdf
322,2012-06-25,浙江医药第六届一次董事会决议公告,/disclosure/listedinfo/announcement/c/2012-06-25/600216_20120625_2.pdf
323,2012-06-25,浙江医药2011年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-06-25/600216_20120625_1.pdf
324,2012-06-25,浙江医药2011年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2012-06-25/600216_20120625_5.pdf
325,2012-06-28,浙江医药公司章程（2012修订）,/disclosure/listedinfo/announcement/c/2012-06-28/600216_20120628_g.pdf
326,2012-06-28,浙江医药2012年第二次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2012-06-28/600216_20120628_1.pdf
327,2012-06-28,浙江医药2012年第二次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2012-06-28/600216_20120628_2.pdf
328,2012-06-30,浙江医药2011年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2012-06-30/600216_20120630_1.pdf
329,2012-07-24,浙江医药关于公司下属主要生产企业停产检修的公告,/disclosure/listedinfo/announcement/c/2012-07-24/600216_20120724_1.pdf
330,2012-08-04,浙江医药关于非公开发行A股股票申请获得中国证券监督管理委员会核准的公告,/disclosure/listedinfo/announcement/c/2012-08-04/600216_20120804_1.pdf
331,2012-08-08,浙江医药产品提价公告,/disclosure/listedinfo/announcement/c/2012-08-08/600216_20120808_1.pdf
332,2012-08-15,浙江医药关于为全资子公司提供担保的公告,/disclosure/listedinfo/announcement/c/2012-08-15/600216_20120815_2.pdf
333,2012-08-15,浙江医药第六届二次董事会决议公告,/disclosure/listedinfo/announcement/c/2012-08-15/600216_20120815_1.pdf
334,2012-08-28,浙江医药非公开发行股票发行情况报告书,/disclosure/listedinfo/announcement/c/2012-08-28/600216_20120828_2.pdf
335,2012-08-28,浙江医药非公开发行股票发行结果暨股份变动公告,/disclosure/listedinfo/announcement/c/2012-08-28/600216_20120828_1.pdf
336,2012-08-30,浙江医药半年报摘要,/disclosure/listedinfo/announcement/c/2012-08-30/600216_2012_zzy.pdf
337,2012-08-30,浙江医药半年报,/disclosure/listedinfo/announcement/c/2012-08-30/600216_2012_z.pdf
338,2012-09-06,浙江医药关于签署募集资金专户存储监管协议的公告,/disclosure/listedinfo/announcement/c/2012-09-06/600216_20120906_2.pdf
339,2012-09-06,浙江医药第六届四次董事会决议公告,/disclosure/listedinfo/announcement/c/2012-09-06/600216_20120906_1.pdf
340,2012-10-09,浙江医药关于辅酶Q10涉诉事项最新进展的公告,/disclosure/listedinfo/announcement/c/2012-10-09/600216_20121009_1.pdf
341,2012-10-20,浙江医药关于下属全资子公司浙江昌海生物有限公司与绍兴市滨海新城管理委员会签署《生物产业园项目二期投资建设协议》的公告,/disclosure/listedinfo/announcement/c/2012-10-20/600216_20121020_2.pdf
342,2012-10-20,浙江医药第六届五次董事会决议公告,/disclosure/listedinfo/announcement/c/2012-10-20/600216_20121020_1.pdf
343,2012-10-31,浙江医药关于以募集资金置换预先已投入募投项目自筹资金的公告,/disclosure/listedinfo/announcement/c/2012-10-31/600216_20121031_3.pdf
344,2012-10-31,浙江医药第三季度季报,/disclosure/listedinfo/announcement/c/2012-10-31/600216_2012_3.pdf
345,2012-10-31,浙江医药第六届三次监事会决议公告,/disclosure/listedinfo/announcement/c/2012-10-31/600216_20121031_2.pdf
346,2012-10-31,浙江医药第六届六次董事会决议公告,/disclosure/listedinfo/announcement/c/2012-10-31/600216_20121031_1.pdf
347,2012-12-05,浙江医药关于辅酶Q10涉诉事项最新进展的公告,/disclosure/listedinfo/announcement/c/2012-12-05/600216_20121205_1.pdf
348,2013-01-31,浙江医药关于变更保荐机构的公告,/disclosure/listedinfo/announcement/c/2013-01-30/600216_20130131_1.pdf
349,2013-02-02,浙江医药第六届七次董事会决议公告,/disclosure/listedinfo/announcement/c/2013-02-01/600216_20130202_1.pdf
350,2013-03-16,浙江医药报表,/disclosure/listedinfo/announcement/c/2013-03-15/600216_20130316_2.pdf
351,2013-03-16,浙江医药2012年度业绩快报,/disclosure/listedinfo/announcement/c/2013-03-15/600216_20130316_1.pdf
352,2013-04-13,浙江医药召开2012年度股东大会的通知,/disclosure/listedinfo/announcement/c/2013-04-12/600216_20130413_6.pdf
353,2013-04-13,浙江医药年报摘要,/disclosure/listedinfo/announcement/c/2013-04-12/600216_2012_nzy.pdf
354,2013-04-13,浙江医药年报,/disclosure/listedinfo/announcement/c/2013-04-12/600216_2012_n.pdf
355,2013-04-13,浙江医药募集资金年度存放与使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2013-04-12/600216_20130413_15.pdf
356,2013-04-13,浙江医药六届四次监事会决议公告,/disclosure/listedinfo/announcement/c/2013-04-12/600216_20130413_4.pdf
357,2013-04-13,浙江医药关于修改《公司章程》的公告,/disclosure/listedinfo/announcement/c/2013-04-12/600216_20130413_8.pdf
358,2013-04-13,浙江医药关于募集资金年度存放与使用情况的专项报告,/disclosure/listedinfo/announcement/c/2013-04-12/600216_20130413_5.pdf
359,2013-04-13,浙江医药关于举行投资者接待日活动的公告,/disclosure/listedinfo/announcement/c/2013-04-12/600216_20130413_7.pdf
360,2013-04-13,浙江医药非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2013-04-12/600216_20130413_14.pdf
361,2013-04-13,浙江医药独立董事关于公司对外担保情况的专项说明及独立意见,/disclosure/listedinfo/announcement/c/2013-04-12/600216_20130413_12.pdf
362,2013-04-13,浙江医药独立董事对公司六届八次董事会有关事项发表的独立意见,/disclosure/listedinfo/announcement/c/2013-04-12/600216_20130413_11.pdf
363,2013-04-13,浙江医药第六届八次董事会决议公告,/disclosure/listedinfo/announcement/c/2013-04-12/600216_20130413_3.pdf
364,2013-04-13,浙江医药2012年度审计报告,/disclosure/listedinfo/announcement/c/2013-04-12/600216_20130413_13.pdf
365,2013-04-13,浙江医药2012年度募集资金存放与使用情况的专项核查意见,/disclosure/listedinfo/announcement/c/2013-04-12/600216_20130413_16.pdf
366,2013-04-13,浙江医药2012年度独立董事工作报告,/disclosure/listedinfo/announcement/c/2013-04-12/600216_20130413_10.pdf
367,2013-04-13,浙江医药2012年度持续督导报告书,/disclosure/listedinfo/announcement/c/2013-04-12/600216_20130413_17.pdf
368,2013-04-25,浙江医药募集资金管理制度,/disclosure/listedinfo/announcement/c/2013-04-24/600216_20130425_6.pdf
369,2013-04-25,浙江医药关于增加2012年年度股东大会提案的公告,/disclosure/listedinfo/announcement/c/2013-04-24/600216_20130425_4.pdf
370,2013-04-25,浙江医药第一季度季报,/disclosure/listedinfo/announcement/c/2013-04-24/600216_2013_1.pdf
371,2013-04-25,浙江医药第六届九次董事会决议公告,/disclosure/listedinfo/announcement/c/2013-04-24/600216_20130425_3.pdf
372,2013-05-11,浙江医药2012年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2013-05-10/600216_20130511_1.pdf
373,2013-05-15,浙江医药关于更换持续督导保荐代表人的公告,/disclosure/listedinfo/announcement/c/2013-05-14/600216_20130515_1.pdf
374,2013-05-17,浙江医药公司章程,/disclosure/listedinfo/announcement/c/2013-05-16/600216_20130517_3.pdf
375,2013-05-17,浙江医药2012年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2013-05-16/600216_20130517_1.pdf
376,2013-05-17,浙江医药2012年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2013-05-16/600216_20130517_2.pdf
377,2013-05-28,浙江医药关于为全资子公司浙江来益医药有限公司银行授信提供担保的公告,/disclosure/listedinfo/announcement/c/2013-05-27/600216_20130528_2.pdf
378,2013-05-28,浙江医药第六届十次董事会决议公告,/disclosure/listedinfo/announcement/c/2013-05-27/600216_20130528_1.pdf
379,2013-06-06,浙江医药2012年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2013-06-05/600216_20130606_1.pdf
380,2013-06-17,"浙江医药关于与AMBRX,Inc.签署《合作开发和许可协议》的公告",/disclosure/listedinfo/announcement/c/2013-06-16/600216_20130617_2.pdf
381,2013-06-17,浙江医药第六届十一次董事会决议公告,/disclosure/listedinfo/announcement/c/2013-06-16/600216_20130617_1.pdf
382,2013-08-10,浙江医药2013年半年度业绩快报公告,/disclosure/listedinfo/announcement/c/2013-08-09/600216_20130810_1.pdf
383,2013-08-20,浙江医药非公开发行限售股上市流通公告,/disclosure/listedinfo/announcement/c/2013-08-19/600216_20130820_1.pdf
384,2013-08-20,浙江医药非公开发行股票限售股解禁的核查意见,/disclosure/listedinfo/announcement/c/2013-08-19/600216_20130820_2.pdf
385,2013-08-31,浙江医药审计报告,/disclosure/listedinfo/announcement/c/2013-08-30/600216_20130831_10.pdf
386,2013-08-31,浙江医药关于召开2013年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2013-08-30/600216_20130831_5.pdf
387,2013-08-31,浙江医药独立董事对公司《2013年半年度资本公积金转增股本预案》发表的独立意见,/disclosure/listedinfo/announcement/c/2013-08-30/600216_20130831_7.pdf
388,2013-08-31,浙江医药董事会对董事长的授权细则,/disclosure/listedinfo/announcement/c/2013-08-30/600216_20130831_8.pdf
389,2013-08-31,浙江医药第六届十二次董事会决议公告,/disclosure/listedinfo/announcement/c/2013-08-30/600216_20130831_2.pdf
390,2013-08-31,浙江医药第六届六次监事会决议公告,/disclosure/listedinfo/announcement/c/2013-08-30/600216_20130831_3.pdf
391,2013-08-31,浙江医药半年报摘要,/disclosure/listedinfo/announcement/c/2013-08-30/600216_2013_zzy.pdf
392,2013-08-31,浙江医药半年报,/disclosure/listedinfo/announcement/c/2013-08-30/600216_2013_z.pdf
393,2013-08-31,浙江医药2013年半年度募集资金存放与实际使用情况的专项报告,/disclosure/listedinfo/announcement/c/2013-08-30/600216_20130831_4.pdf
394,2013-09-06,浙江医药关于2013年第一次临时股东大会增加临时提案的公告,/disclosure/listedinfo/announcement/c/2013-09-05/600216_20130906_1.pdf
395,2013-09-11,浙江医药2013年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2013-09-10/600216_20130911_1.pdf
396,2013-09-17,浙江医药公司章程（2013修订）,/disclosure/listedinfo/announcement/c/2013-09-16/600216_20130917_3.pdf
397,2013-09-17,浙江医药2013年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2013-09-16/600216_20130917_1.pdf
398,2013-09-17,浙江医药2013年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2013-09-16/600216_20130917_2.pdf
399,2013-09-26,浙江医药关于年产2万吨高含量维生素E项目试生产公告,/disclosure/listedinfo/announcement/c/2013-09-25/600216_20130926_3.pdf
400,2013-09-26,浙江医药2013年半年度资本公积金转增股本实施公告,/disclosure/listedinfo/announcement/c/2013-09-25/600216_20130926_2.pdf
401,2013-10-30,浙江医药第三季度季报,/disclosure/listedinfo/announcement/c/2013-10-29/600216_2013_3.pdf
402,2014-02-14,浙江医药关于控股股东、实际控制人等相关方承诺及履行情况的公告,/disclosure/listedinfo/announcement/c/2014-02-13/600216_20140214_1.pdf
403,2014-03-28,浙江医药审计委员会实施细则,/disclosure/listedinfo/announcement/c/2014-03-27/600216_20140328_24.pdf
404,2014-03-28,浙江医药年报摘要,/disclosure/listedinfo/announcement/c/2014-03-27/600216_2013_nzy.pdf
405,2014-03-28,浙江医药年报,/disclosure/listedinfo/announcement/c/2014-03-27/600216_2013_n.pdf
406,2014-03-28,浙江医药内部控制审计报告,/disclosure/listedinfo/announcement/c/2014-03-27/600216_20140328_18.pdf
407,2014-03-28,浙江医药内部控制缺陷认定标准,/disclosure/listedinfo/announcement/c/2014-03-27/600216_20140328_23.pdf
408,2014-03-28,浙江医药募集资金存放与使用情况鉴证报告,/disclosure/listedinfo/announcement/c/2014-03-27/600216_20140328_11.pdf
409,2014-03-28,浙江医药关于召开2013年度股东大会的通知,/disclosure/listedinfo/announcement/c/2014-03-27/600216_20140328_5.pdf
410,2014-03-28,浙江医药关于修改《公司章程》的公告,/disclosure/listedinfo/announcement/c/2014-03-27/600216_20140328_3.pdf
411,2014-03-28,浙江医药关于下属全资子公司浙江昌海生物有限公司取得240亩二期建设用地的公告,/disclosure/listedinfo/announcement/c/2014-03-27/600216_20140328_8.pdf
412,2014-03-28,浙江医药关于年产2万吨高含量维生素E项目完成试生产的公告,/disclosure/listedinfo/announcement/c/2014-03-27/600216_20140328_7.pdf
413,2014-03-28,浙江医药关于举行投资者接待日活动的公告,/disclosure/listedinfo/announcement/c/2014-03-27/600216_20140328_6.pdf
414,2014-03-28,浙江医药关联交易决策规则,/disclosure/listedinfo/announcement/c/2014-03-27/600216_20140328_22.pdf
415,2014-03-28,浙江医药非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2014-03-27/600216_20140328_15.pdf
416,2014-03-28,浙江医药独立董事制度,/disclosure/listedinfo/announcement/c/2014-03-27/600216_20140328_21.pdf
417,2014-03-28,浙江医药独立董事关于公司对外担保情况的专项说明及独立意见,/disclosure/listedinfo/announcement/c/2014-03-27/600216_20140328_13.pdf
418,2014-03-28,浙江医药独立董事对公司2013年度利润分配方案发表的独立意见,/disclosure/listedinfo/announcement/c/2014-03-27/600216_20140328_25.pdf
419,2014-03-28,浙江医药独立董事2013年度述职报告,/disclosure/listedinfo/announcement/c/2014-03-27/600216_20140328_16.pdf
420,2014-03-28,浙江医药董事会审计委员会2013年度履职情况报告,/disclosure/listedinfo/announcement/c/2014-03-27/600216_20140328_20.pdf
421,2014-03-28,浙江医药第六届十五次董事会决议公告,/disclosure/listedinfo/announcement/c/2014-03-27/600216_20140328_1.pdf
422,2014-03-28,浙江医药第六届八次监事会决议公告,/disclosure/listedinfo/announcement/c/2014-03-27/600216_20140328_2.pdf
423,2014-03-28,浙江医药：东方花旗证券有限公司关于浙江医药股份有限公司2013年度募集资金存放与使用情况的专项核查意见,/disclosure/listedinfo/announcement/c/2014-03-27/600216_20140328_10.pdf
424,2014-03-28,浙江医药：东方花旗证券有限公司关于浙江医药股份有限公司2013年度持续督导报告书,/disclosure/listedinfo/announcement/c/2014-03-27/600216_20140328_26.pdf
425,2014-03-28,浙江医药2013年度审计报告,/disclosure/listedinfo/announcement/c/2014-03-27/600216_20140328_14.pdf
426,2014-03-28,浙江医药2013年度内部控制自我评价报告,/disclosure/listedinfo/announcement/c/2014-03-27/600216_20140328_17.pdf
427,2014-03-28,浙江医药2013年度募集资金存放与使用情况的专项报告,/disclosure/listedinfo/announcement/c/2014-03-27/600216_20140328_4.pdf
428,2014-04-09,浙江医药：东方花旗证券有限公司关于浙江医药股份有限公司2012年非公开发行股票之保荐总结报告书,/disclosure/listedinfo/announcement/c/2014-04-08/600216_20140409_1.pdf
429,2014-04-12,浙江医药2013年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2014-04-11/600216_20140412_1.pdf
430,2014-04-19,浙江医药公司章程（2014修订）,/disclosure/listedinfo/announcement/c/2014-04-18/600216_20140419_3.pdf
431,2014-04-19,浙江医药2013年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2014-04-18/600216_20140419_1.pdf
432,2014-04-19,浙江医药2013年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2014-04-18/600216_20140419_2.pdf
433,2014-04-26,浙江医药第一季度季报,/disclosure/listedinfo/announcement/c/2014-04-25/600216_2014_1.pdf
434,2014-05-14,浙江医药关于原料药取得欧洲药品质量管理局批准证书的公告,/disclosure/listedinfo/announcement/c/2014-05-13/600216_20140514_1.pdf
435,2014-05-20,浙江医药2013年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2014-05-19/600216_20140520_2.pdf
436,2014-05-31,浙江医药关于完成工商变更登记的公告,/disclosure/listedinfo/announcement/c/2014-05-30/600216_20140531_1.pdf
437,2014-07-12,浙江医药关于公司总部办公场所迁址的公告,/disclosure/listedinfo/announcement/c/2014-07-11/600216_20140712_1.pdf
438,2014-08-14,浙江医药半年报摘要,/disclosure/listedinfo/announcement/c/2014-08-13/600216_2014_zzy.pdf
439,2014-08-14,浙江医药半年报,/disclosure/listedinfo/announcement/c/2014-08-13/600216_2014_z.pdf
440,2014-09-13,浙江医药章程修正案,/disclosure/listedinfo/announcement/c/2014-09-12/600216_20140913_5.pdf
441,2014-09-13,浙江医药关于召开2014年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2014-09-12/600216_20140913_4.pdf
442,2014-09-13,浙江医药关于增加公司经营范围并修订《公司章程》的公告,/disclosure/listedinfo/announcement/c/2014-09-12/600216_20140913_3.pdf
443,2014-09-13,浙江医药关于吸收合并全资子公司浙江昌海生物有限公司并设立分公司的公告,/disclosure/listedinfo/announcement/c/2014-09-12/600216_20140913_2.pdf
444,2014-09-13,浙江医药第六届十八次董事会决议公告,/disclosure/listedinfo/announcement/c/2014-09-12/600216_20140913_1.pdf
445,2014-09-24,浙江医药2014年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2014-09-23/600216_20140924_1.pdf
446,2014-09-30,浙江医药公司章程（2014修订）,/disclosure/listedinfo/announcement/c/2014-09-29/600216_20140930_3.pdf
447,2014-09-30,浙江医药2014年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2014-09-29/600216_20140930_1.pdf
448,2014-09-30,浙江医药2014年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2014-09-29/600216_20140930_2.pdf
449,2014-10-29,浙江医药关于会计政策变更的公告,/disclosure/listedinfo/announcement/c/2014-10-28/600216_20141029_4.pdf
450,2014-10-29,浙江医药独立董事关于会计政策变更的独立意见,/disclosure/listedinfo/announcement/c/2014-10-28/600216_20141029_6.pdf
451,2014-10-29,浙江医药第三季度季报,/disclosure/listedinfo/announcement/c/2014-10-28/600216_2014_3.pdf
452,2014-10-29,浙江医药第六届十一次监事会决议公告,/disclosure/listedinfo/announcement/c/2014-10-28/600216_20141029_3.pdf
453,2014-10-29,浙江医药第六届十九次董事会决议公告,/disclosure/listedinfo/announcement/c/2014-10-28/600216_20141029_2.pdf
454,2015-01-24,浙江医药独立董事关于核销有关资产的独立意见,/disclosure/listedinfo/announcement/c/2015-01-23/600216_20150124_4.pdf
455,2015-01-24,浙江医药第六届十二次监事会决议公告,/disclosure/listedinfo/announcement/c/2015-01-23/600216_20150124_2.pdf
456,2015-01-24,浙江医药第六届二十次董事会决议公告,/disclosure/listedinfo/announcement/c/2015-01-23/600216_20150124_1.pdf
457,2015-01-24,浙江医药2014年年度业绩预减公告,/disclosure/listedinfo/announcement/c/2015-01-23/600216_20150124_3.pdf
458,2015-03-28,浙江医药关于再次被认定为高新技术企业的公告,/disclosure/listedinfo/announcement/c/2015-03-27/600216_20150328_1.pdf
459,2015-04-10,浙江医药关于出售部分可供出售金融资产的公告,/disclosure/listedinfo/announcement/c/2015-04-09/600216_20150410_1.pdf
460,2015-04-25,浙江医药年报摘要,/disclosure/listedinfo/announcement/c/2015-04-24/600216_2014_nzy.pdf
461,2015-04-25,浙江医药年报,/disclosure/listedinfo/announcement/c/2015-04-24/600216_2014_n.pdf
462,2015-04-25,浙江医药内部控制审计报告,/disclosure/listedinfo/announcement/c/2015-04-24/600216_20150425_14.pdf
463,2015-04-25,浙江医药关于与AMBRX Inc.合作开发产品进展的公告,/disclosure/listedinfo/announcement/c/2015-04-24/600216_20150425_7.pdf
464,2015-04-25,浙江医药关于拟出售部分可供出售金融资产的公告,/disclosure/listedinfo/announcement/c/2015-04-24/600216_20150425_6.pdf
465,2015-04-25,浙江医药关于调整《生命营养品、特色原料药及制剂出口基地建设项目》部分实施内容的公告,/disclosure/listedinfo/announcement/c/2015-04-24/600216_20150425_5.pdf
466,2015-04-25,浙江医药独立董事关于公司对外担保情况的专项说明及独立意见,/disclosure/listedinfo/announcement/c/2015-04-24/600216_20150425_9.pdf
467,2015-04-25,浙江医药独立董事2014年度述职报告,/disclosure/listedinfo/announcement/c/2015-04-24/600216_20150425_12.pdf
468,2015-04-25,浙江医药董事会审计委员会2014年度履职情况报告,/disclosure/listedinfo/announcement/c/2015-04-24/600216_20150425_15.pdf
469,2015-04-25,浙江医药第一季度季报,/disclosure/listedinfo/announcement/c/2015-04-24/600216_2015_1.pdf
470,2015-04-25,浙江医药第六届十三次监事会决议公告,/disclosure/listedinfo/announcement/c/2015-04-24/600216_20150425_4.pdf
471,2015-04-25,浙江医药第六届二十一次董事会决议公告,/disclosure/listedinfo/announcement/c/2015-04-24/600216_20150425_3.pdf
472,2015-04-25,浙江医药：非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2015-04-24/600216_20150425_11.pdf
473,2015-04-25,浙江医药2014年度审计报告,/disclosure/listedinfo/announcement/c/2015-04-24/600216_20150425_10.pdf
474,2015-04-25,浙江医药2014年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2015-04-24/600216_20150425_13.pdf
475,2015-04-29,浙江医药关于辅酶Q10产品涉诉事项德国诉讼案最新进展公告,/disclosure/listedinfo/announcement/c/2015-04-28/600216_20150429_1.pdf
476,2015-05-21,浙江医药六届十四次监事会决议公告,/disclosure/listedinfo/announcement/c/2015-05-20/600216_20150521_2.pdf
477,2015-05-21,浙江医药六届二十二次董事会决议公告,/disclosure/listedinfo/announcement/c/2015-05-20/600216_20150521_1.pdf
478,2015-05-21,浙江医药关于召开2014年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2015-05-20/600216_20150521_4.pdf
479,2015-05-21,浙江医药关于修改《公司章程》和《股东大会议事规则》的公告,/disclosure/listedinfo/announcement/c/2015-05-20/600216_20150521_3.pdf
480,2015-05-21,浙江医药关于第七届监事会职工监事选举结果的公告,/disclosure/listedinfo/announcement/c/2015-05-20/600216_20150521_5.pdf
481,2015-05-21,浙江医药股东大会议事规则,/disclosure/listedinfo/announcement/c/2015-05-20/600216_20150521_13.pdf
482,2015-05-21,浙江医药公司章程（2015修订）,/disclosure/listedinfo/announcement/c/2015-05-20/600216_20150521_12.pdf
483,2015-05-21,浙江医药独立董事提名人声明,/disclosure/listedinfo/announcement/c/2015-05-20/600216_20150521_6.pdf
484,2015-05-21,浙江医药独立董事候选人声明（朱建伟）,/disclosure/listedinfo/announcement/c/2015-05-20/600216_20150521_10.pdf
485,2015-05-21,浙江医药独立董事候选人声明（吴弘）,/disclosure/listedinfo/announcement/c/2015-05-20/600216_20150521_8.pdf
486,2015-05-21,浙江医药独立董事候选人声明（黄董良）,/disclosure/listedinfo/announcement/c/2015-05-20/600216_20150521_9.pdf
487,2015-05-21,浙江医药独立董事侯选人声明（彭师奇）,/disclosure/listedinfo/announcement/c/2015-05-20/600216_20150521_7.pdf
488,2015-05-21,浙江医药独立董事对公司董事会换届选举的独立意见,/disclosure/listedinfo/announcement/c/2015-05-20/600216_20150521_11.pdf
489,2015-06-06,浙江医药关于召开2014年年度股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2015-06-05/600216_20150606_1.pdf
490,2015-06-06,浙江医药2014年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2015-06-05/600216_20150606_2.pdf
491,2015-06-12,浙江医药公司章程（2015修订）,/disclosure/listedinfo/announcement/c/2015-06-11/600216_20150612_3.pdf
492,2015-06-12,浙江医药2014年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2015-06-11/600216_20150612_1.pdf
493,2015-06-12,浙江医药2014年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2015-06-11/600216_20150612_2.pdf
494,2015-06-13,浙江医药第七届一次监事会决议公告,/disclosure/listedinfo/announcement/c/2015-06-12/600216_20150613_2.pdf
495,2015-06-13,浙江医药第七届一次董事会决议公告,/disclosure/listedinfo/announcement/c/2015-06-12/600216_20150613_1.pdf
496,2015-06-13,浙江医药：关于公司总裁等高管人员的提名、聘任的独立意见,/disclosure/listedinfo/announcement/c/2015-06-12/600216_20150613_3.pdf
497,2015-06-27,浙江医药关于出售部分可供出售金融资产的公告,/disclosure/listedinfo/announcement/c/2015-06-26/600216_20150627_1.pdf
498,2015-07-07,浙江医药关于实际控制人的一致行动人增持公司股份的公告,/disclosure/listedinfo/announcement/c/2015-07-06/600216_20150707_1.pdf
499,2015-07-09,浙江医药关于公司高管增持公司股份的公告,/disclosure/listedinfo/announcement/c/2015-07-08/600216_20150709_1.pdf
500,2015-07-10,浙江医药关于控股股东及实际控制人承诺不减持公司股份等事项的公告,/disclosure/listedinfo/announcement/c/2015-07-09/600216_20150710_1.pdf
501,2015-07-10,浙江医药关于公司董事、高管增持公司股份的公告,/disclosure/listedinfo/announcement/c/2015-07-09/600216_20150710_2.pdf
502,2015-07-17,浙江医药2014年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2015-07-16/600216_20150717_1.pdf
503,2015-08-06,浙江医药关于公司重大创新药物研发进展的公告,/disclosure/listedinfo/announcement/c/2015-08-06/600216_20150806_1.pdf
504,2015-08-21,浙江医药关于前十名股东持股情况的公告,/disclosure/listedinfo/announcement/c/2015-08-21/600216_20150821_1.pdf
505,2015-08-28,浙江医药独立董事关于修订《浙江医药股份有限公司高级管理人员薪酬方案》的独立意见,/disclosure/listedinfo/announcement/c/2015-08-28/600216_20150828_4.pdf
506,2015-08-28,浙江医药第七届二次董事会决议公告,/disclosure/listedinfo/announcement/c/2015-08-28/600216_20150828_2.pdf
507,2015-08-28,浙江医药半年报摘要,/disclosure/listedinfo/announcement/c/2015-08-28/600216_2015_zzy.pdf
508,2015-08-28,浙江医药半年报,/disclosure/listedinfo/announcement/c/2015-08-28/600216_2015_z.pdf
509,2015-10-09,浙江医药关于抗HER2-ADC获得新西兰临床试验许可的公告,/disclosure/listedinfo/announcement/c/2015-10-09/600216_20151009_1.pdf
510,2015-10-28,浙江医药第三季度季报,/disclosure/listedinfo/announcement/c/2015-10-28/600216_2015_3.pdf
511,2015-11-11,浙江医药关于实际控制人的一致行动人完成增持公司股份计划的公告,/disclosure/listedinfo/announcement/c/2015-11-11/600216_20151111_1.pdf
512,2015-12-03,浙江医药关于控股子公司浙江海隆生物科技有限公司与北京中海生物科技有限公司、金宇保灵生物药品有限公司签订猪瘟疫苗联合研制协议的公告,/disclosure/listedinfo/announcement/c/2015-12-03/600216_20151203_2.pdf
513,2015-12-03,浙江医药关于辅酶Q10产品涉诉事项美国诉讼案最新进展公告,/disclosure/listedinfo/announcement/c/2015-12-03/600216_20151203_1.pdf
514,2015-12-04,浙江医药关于控股子公司浙江海隆生物科技有限公司与北京中海生物科技有限公司、金宇保灵生物药品有限公司签订猪瘟疫苗联合研制协议的补充公告,/disclosure/listedinfo/announcement/c/2015-12-04/600216_20151204_1.pdf
515,2015-12-08,浙江医药关于创新药苹果酸奈诺沙星注射剂Ⅲ期临床试验进展的提示性公告,/disclosure/listedinfo/announcement/c/2015-12-08/600216_20151208_1.pdf
516,2015-12-30,浙江医药关于甲磺酸普喹替尼片获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2015-12-30/600216_20151230_1.pdf
517,2015-12-31,浙江医药关于盐酸头孢唑兰获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2015-12-31/600216_20151231_1.pdf
518,2016-01-06,浙江医药关于撤回西罗莫司片药品注册申请的公告,/disclosure/listedinfo/announcement/c/2016-01-06/600216_20160106_1.pdf
519,2016-01-21,浙江医药关于溴夫定及其片剂获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-01-21/600216_20160121_1.pdf
520,2016-01-21,浙江医药关于药品注册申请获得受理的公告,/disclosure/listedinfo/announcement/c/2016-01-21/600216_20160121_2.pdf
521,2016-01-22,浙江医药关于撤回头孢克洛胶囊药品注册申请的公告,/disclosure/listedinfo/announcement/c/2016-01-22/600216_20160122_1.pdf
522,2016-03-08,浙江医药关于与华海（美国）国际有限公司签署战略合作框架协议的公告,/disclosure/listedinfo/announcement/c/2016-03-08/600216_20160308_2.pdf
523,2016-03-08,浙江医药关于抗肿瘤创新药XCCS605B获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-03-08/600216_20160308_1.pdf
524,2016-03-08,浙江医药关于变更证券事务代表的公告,/disclosure/listedinfo/announcement/c/2016-03-08/600216_20160308_3.pdf
525,2016-03-25,浙江医药澄清公告,/disclosure/listedinfo/announcement/c/2016-03-25/600216_20160325_1.pdf
526,2016-04-07,浙江医药关于对全资子公司增资的公告,/disclosure/listedinfo/announcement/c/2016-04-07/600216_20160407_2.pdf
527,2016-04-07,浙江医药第七届董事会第四次（临时）会议决议公告,/disclosure/listedinfo/announcement/c/2016-04-07/600216_20160407_1.pdf
528,2016-04-28,浙江医药关于召开2015年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2016-04-28/600216_20160428_6.pdf
529,2016-04-28,浙江医药关于现金分红情况说明的公告,/disclosure/listedinfo/announcement/c/2016-04-28/600216_20160428_1.pdf
530,2016-04-28,浙江医药独立董事关于提名董事候选人的独立意见,/disclosure/listedinfo/announcement/c/2016-04-28/600216_20160428_10.pdf
531,2016-04-28,浙江医药独立董事对公司2015年度利润分配方案发表的独立意见,/disclosure/listedinfo/announcement/c/2016-04-28/600216_20160428_9.pdf
532,2016-04-28,浙江医药独立董事2015年度述职报告,/disclosure/listedinfo/announcement/c/2016-04-28/600216_20160428_14.pdf
533,2016-04-28,浙江医药董事会审计委员会2015年度履职情况报告,/disclosure/listedinfo/announcement/c/2016-04-28/600216_20160428_7.pdf
534,2016-04-28,浙江医药第七届五次董事会决议公告,/disclosure/listedinfo/announcement/c/2016-04-28/600216_20160428_4.pdf
535,2016-04-28,浙江医药第七届四次监事会决议公告,/disclosure/listedinfo/announcement/c/2016-04-28/600216_20160428_5.pdf
536,2016-04-28,浙江医药：审计报告,/disclosure/listedinfo/announcement/c/2016-04-28/600216_20160428_12.pdf
537,2016-04-28,浙江医药：内部控制审计报告,/disclosure/listedinfo/announcement/c/2016-04-28/600216_20160428_16.pdf
538,2016-04-28,浙江医药：非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2016-04-28/600216_20160428_13.pdf
539,2016-04-28,浙江医药2016年第一季度报告,/disclosure/listedinfo/announcement/c/2016-04-28/600216_2016_1.pdf
540,2016-04-28,浙江医药2015年年度报告摘要,/disclosure/listedinfo/announcement/c/2016-04-28/600216_2015_nzy.pdf
541,2016-04-28,浙江医药2015年年度报告,/disclosure/listedinfo/announcement/c/2016-04-28/600216_2015_n.pdf
542,2016-04-28,浙江医药2015年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2016-04-28/600216_20160428_15.pdf
543,2016-05-05,浙江医药关于召开2015年度网上业绩说明会的通知,/disclosure/listedinfo/announcement/c/2016-05-05/600216_20160505_1.pdf
544,2016-05-10,浙江医药关于2015年度网上业绩说明会召开情况的公告,/disclosure/listedinfo/announcement/c/2016-05-10/600216_20160510_1.pdf
545,2016-05-24,浙江医药关于设立全资子公司的公告,/disclosure/listedinfo/announcement/c/2016-05-24/600216_20160524_3.pdf
546,2016-05-24,浙江医药关于举行投资者接待日活动的公告,/disclosure/listedinfo/announcement/c/2016-05-24/600216_20160524_7.pdf
547,2016-05-24,浙江医药关于变更注册地及修改《公司章程》部分条款的公告,/disclosure/listedinfo/announcement/c/2016-05-24/600216_20160524_2.pdf
548,2016-05-24,浙江医药关于2015年年度股东大会增加临时提案的公告,/disclosure/listedinfo/announcement/c/2016-05-24/600216_20160524_4.pdf
549,2016-05-24,浙江医药公司章程（2016修订）,/disclosure/listedinfo/announcement/c/2016-05-24/600216_20160524_5.pdf
550,2016-05-24,浙江医药第七届六次董事会决议公告,/disclosure/listedinfo/announcement/c/2016-05-24/600216_20160524_1.pdf
551,2016-05-24,浙江医药2015年年度股东大会资料,/disclosure/listedinfo/announcement/c/2016-05-24/600216_20160524_6.pdf
552,2016-06-02,浙江医药关于注射用达托霉素在美国FDA新药申请进展的公告,/disclosure/listedinfo/announcement/c/2016-06-02/600216_20160602_2.pdf
553,2016-06-02,浙江医药关于召开2015年年度股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2016-06-02/600216_20160602_1.pdf
554,2016-06-08,浙江医药公司章程（2016修订）,/disclosure/listedinfo/announcement/c/2016-06-08/600216_20160608_4.pdf
555,2016-06-08,浙江医药第七届五次监事会决议公告,/disclosure/listedinfo/announcement/c/2016-06-08/600216_20160608_2.pdf
556,2016-06-08,浙江医药2015年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-06-08/600216_20160608_1.pdf
557,2016-06-08,浙江医药2015年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-06-08/600216_20160608_3.pdf
558,2016-06-13,浙江医药关于创新药苹果酸奈诺沙星及其胶囊获得药品批准文号的公告,/disclosure/listedinfo/announcement/c/2016-06-13/600216_20160613_1.pdf
559,2016-06-14,浙江医药关于辅酶Q10产品涉诉事项德国诉讼案最新进展的公告,/disclosure/listedinfo/announcement/c/2016-06-14/600216_20160614_2.pdf
560,2016-06-14,浙江医药关于创新药苹果酸奈诺沙星及其胶囊获得药品批准文号的补充公告,/disclosure/listedinfo/announcement/c/2016-06-14/600216_20160614_1.pdf
561,2016-06-29,浙江医药公告,/disclosure/listedinfo/announcement/c/2016-06-29/600216_20160629_1.pdf
562,2016-07-08,浙江医药2015年度利润分配实施公告,/disclosure/listedinfo/announcement/c/2016-07-08/600216_20160708_1.pdf
563,2016-07-28,浙江医药关于注册地完成工商变更登记的公告,/disclosure/listedinfo/announcement/c/2016-07-28/600216_20160728_2.pdf
564,2016-07-28,浙江医药关于签订药品合作协议书的公告,/disclosure/listedinfo/announcement/c/2016-07-28/600216_20160728_1.pdf
565,2016-08-11,浙江医药关于FDA对公司下属企业新昌制药厂原料药检查出具警告信的公告,/disclosure/listedinfo/announcement/c/2016-08-11/600216_20160811_6.pdf
566,2016-08-12,浙江医药关于FDA对公司下属企业新昌制药厂原料药检查出具警告信的补充公告,/disclosure/listedinfo/announcement/c/2016-08-12/600216_20160812_1.pdf
567,2016-08-13,浙江医药重大事项停牌公告,/disclosure/listedinfo/announcement/c/2016-08-13/600216_20160813_1.pdf
568,2016-08-19,浙江医药关于与Ambrx公司合作开发产品进展的公告,/disclosure/listedinfo/announcement/c/2016-08-19/600216_20160819_1.pdf
569,2016-08-20,浙江医药首期限制性股票激励计划实施考核管理办法,/disclosure/listedinfo/announcement/c/2016-08-20/600216_20160820_6.pdf
570,2016-08-20,浙江医药首期限制性股票激励计划激励对象名单,/disclosure/listedinfo/announcement/c/2016-08-20/600216_20160820_7.pdf
571,2016-08-20,浙江医药首期限制性股票激励计划（草案）摘要公告,/disclosure/listedinfo/announcement/c/2016-08-20/600216_20160820_3.pdf
572,2016-08-20,浙江医药首期限制性股票激励计划（草案）,/disclosure/listedinfo/announcement/c/2016-08-20/600216_20160820_8.pdf
573,2016-08-20,浙江医药监事会关于公司首期限制性股票激励计划事项发表的意见,/disclosure/listedinfo/announcement/c/2016-08-20/600216_20160820_5.pdf
574,2016-08-20,浙江医药关于公司股票复牌的公告,/disclosure/listedinfo/announcement/c/2016-08-20/600216_20160820_9.pdf
575,2016-08-20,浙江医药独立董事关于公司首期限制性股票激励计划事项的独立意见,/disclosure/listedinfo/announcement/c/2016-08-20/600216_20160820_4.pdf
576,2016-08-20,浙江医药第七届七次董事会决议公告,/disclosure/listedinfo/announcement/c/2016-08-20/600216_20160820_1.pdf
577,2016-08-20,浙江医药第七届六次监事会决议公告,/disclosure/listedinfo/announcement/c/2016-08-20/600216_20160820_2.pdf
578,2016-08-29,浙江医药信息披露暂缓与豁免业务内部管理制度,/disclosure/listedinfo/announcement/c/2016-08-29/600216_20160829_9.pdf
579,2016-08-29,浙江医药关于召开2016年第一次临时股东大会的通知,/disclosure/listedinfo/announcement/c/2016-08-29/600216_20160829_7.pdf
580,2016-08-29,浙江医药关于开展票据池业务的公告,/disclosure/listedinfo/announcement/c/2016-08-29/600216_20160829_5.pdf
581,2016-08-29,浙江医药关于独立董事公开征集委托投票权的公告,/disclosure/listedinfo/announcement/c/2016-08-29/600216_20160829_1.pdf
582,2016-08-29,浙江医药关于变更公司注册地、增加经营范围并修改《公司章程》部分条款的公告,/disclosure/listedinfo/announcement/c/2016-08-29/600216_20160829_6.pdf
583,2016-08-29,浙江医药公司章程（2016修订）,/disclosure/listedinfo/announcement/c/2016-08-29/600216_20160829_11.pdf
584,2016-08-29,浙江医药独立董事关于公司开展票据池业务的独立意见,/disclosure/listedinfo/announcement/c/2016-08-29/600216_20160829_10.pdf
585,2016-08-29,浙江医药第七届七次监事会决议公告,/disclosure/listedinfo/announcement/c/2016-08-29/600216_20160829_4.pdf
586,2016-08-29,浙江医药第七届八次董事会决议公告,/disclosure/listedinfo/announcement/c/2016-08-29/600216_20160829_3.pdf
587,2016-08-29,浙江医药：天相投资顾问有限公司关于浙江医药股份有限公司首期限制性股票激励计划（草案）之独立财务顾问报告,/disclosure/listedinfo/announcement/c/2016-08-29/600216_20160829_13.pdf
588,2016-08-29,浙江医药：国浩律师（上海）事务所关于浙江医药股份有限公司首期限制性股票激励计划之法律意见书,/disclosure/listedinfo/announcement/c/2016-08-29/600216_20160829_12.pdf
589,2016-08-29,浙江医药2016年半年度报告摘要,/disclosure/listedinfo/announcement/c/2016-08-29/600216_2016_zzy.pdf
590,2016-08-29,浙江医药2016年半年度报告,/disclosure/listedinfo/announcement/c/2016-08-29/600216_2016_z.pdf
591,2016-08-30,浙江医药关于FDA对公司下属企业新昌制药厂原料药检查出具警告信的进展公告,/disclosure/listedinfo/announcement/c/2016-08-30/600216_20160830_2.pdf
592,2016-08-30,浙江医药2016年第一次临时股东大会会议资料,/disclosure/listedinfo/announcement/c/2016-08-30/600216_20160830_1.pdf
593,2016-09-07,浙江医药监事会对公司首期限制性股票激励计划激励对象名单的审核及公示情况的说明,/disclosure/listedinfo/announcement/c/2016-09-07/600216_20160907_2.pdf
594,2016-09-07,浙江医药关于召开2016年第一次临时股东大会的提示性公告,/disclosure/listedinfo/announcement/c/2016-09-07/600216_20160907_1.pdf
595,2016-09-13,浙江医药首期限制性股票激励计划,/disclosure/listedinfo/announcement/c/2016-09-13/600216_20160913_5.pdf
596,2016-09-13,浙江医药关于本次限制性股票激励计划内幕信息知情人买卖公司股票情况自查报告,/disclosure/listedinfo/announcement/c/2016-09-13/600216_20160913_2.pdf
597,2016-09-13,浙江医药公司章程（2016修订）,/disclosure/listedinfo/announcement/c/2016-09-13/600216_20160913_4.pdf
598,2016-09-13,浙江医药2016年第一次临时股东大会决议公告,/disclosure/listedinfo/announcement/c/2016-09-13/600216_20160913_1.pdf
599,2016-09-13,浙江医药2016年第一次临时股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2016-09-13/600216_20160913_3.pdf
600,2016-09-27,浙江医药首期限制性股票激励计划首次授予激励对象名单,/disclosure/listedinfo/announcement/c/2016-09-27/600216_20160927_8.pdf
601,2016-09-27,浙江医药关于公司首期限制性股票激励计划首次授予的公告,/disclosure/listedinfo/announcement/c/2016-09-27/600216_20160927_3.pdf
602,2016-09-27,浙江医药独立董事关于限制性股票授予事项的独立意见,/disclosure/listedinfo/announcement/c/2016-09-27/600216_20160927_6.pdf
603,2016-09-27,浙江医药独立董事关于限制性股票授予事项的独立意见,/disclosure/listedinfo/announcement/c/2016-09-27/600216_20160927_4.pdf
604,2016-09-27,浙江医药第七届九次董事会决议公告,/disclosure/listedinfo/announcement/c/2016-09-27/600216_20160927_1.pdf
605,2016-09-27,浙江医药第七届八次监事会决议公告,/disclosure/listedinfo/announcement/c/2016-09-27/600216_20160927_2.pdf
606,2016-09-27,浙江医药：国浩律师（上海）事务所关于浙江医药股份有限公司股权激励计划首次授予限制性股票事项之法律意见书,/disclosure/listedinfo/announcement/c/2016-09-27/600216_20160927_7.pdf
607,2016-09-27,浙江医药：国浩律师（上海）事务所关于浙江医药股份有限公司股权激励计划首次授予限制性股票事项之法律意见书,/disclosure/listedinfo/announcement/c/2016-09-27/600216_20160927_5.pdf
608,2016-10-12,浙江医药关于注册地、经营范围完成工商变更登记的公告,/disclosure/listedinfo/announcement/c/2016-10-12/600216_20161012_2.pdf
609,2016-10-12,浙江医药关于硫酸氢氯吡格雷片获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2016-10-12/600216_20161012_1.pdf
610,2016-10-19,浙江医药关于完成企业集团设立登记的公告,/disclosure/listedinfo/announcement/c/2016-10-19/600216_20161019_1.pdf
611,2016-10-25,浙江医药关于修订《公司章程》的公告,/disclosure/listedinfo/announcement/c/2016-10-25/600216_20161025_2.pdf
612,2016-10-25,浙江医药关于全资子公司浙江来益医药有限公司收购杭州九品大药房有限公司部分股权的公告,/disclosure/listedinfo/announcement/c/2016-10-25/600216_20161025_3.pdf
613,2016-10-25,浙江医药股权激励计划授予结果公告,/disclosure/listedinfo/announcement/c/2016-10-25/600216_20161025_1.pdf
614,2016-10-25,浙江医药公司章程（2016修订）,/disclosure/listedinfo/announcement/c/2016-10-25/600216_20161025_4.pdf
615,2016-10-28,浙江医药2016年第三季度报告,/disclosure/listedinfo/announcement/c/2016-10-28/600216_2016_3.pdf
616,2016-11-08,浙江医药关于注册资本完成工商变更登记的公告,/disclosure/listedinfo/announcement/c/2016-11-08/600216_20161108_1.pdf
617,2016-11-10,浙江医药关于辅酶Q10产品涉诉事项德国诉讼案最新进展的公告,/disclosure/listedinfo/announcement/c/2016-11-10/600216_20161110_1.pdf
618,2017-01-14,浙江医药2016年年度业绩预增公告,/disclosure/listedinfo/announcement/c/2017-01-14/600216_20170114_1.pdf
619,2017-03-01,浙江医药关于公司产品新进入国家医保目录的公告,/disclosure/listedinfo/announcement/c/2017-03-01/600216_20170301_1.pdf
620,2017-03-17,浙江医药关于药物临床试验批件的提示性公告,/disclosure/listedinfo/announcement/c/2017-03-17/600216_20170317_1.pdf
621,2017-03-18,浙江医药关于媒体报道的澄清公告,/disclosure/listedinfo/announcement/c/2017-03-18/600216_20170318_1.pdf
622,2017-03-21,浙江医药关于获得药物临床试验批件的公告,/disclosure/listedinfo/announcement/c/2017-03-21/600216_20170321_1.pdf
623,2017-04-12,浙江医药章程（2017修订）,/disclosure/listedinfo/announcement/c/2017-04-12/600216_20170412_14.pdf
624,2017-04-12,浙江医药关于增加经营范围及修改《公司章程》部分条款的公告,/disclosure/listedinfo/announcement/c/2017-04-12/600216_20170412_3.pdf
625,2017-04-12,浙江医药关于全资子公司浙江来益医药有限公司吸收合并全资子公司杭州来益生命营养科技有限公司暨增资的公告,/disclosure/listedinfo/announcement/c/2017-04-12/600216_20170412_4.pdf
626,2017-04-12,浙江医药独立董事对公司2016年度利润分配方案发表的独立意见,/disclosure/listedinfo/announcement/c/2017-04-12/600216_20170412_13.pdf
627,2017-04-12,浙江医药独立董事2016年度述职报告,/disclosure/listedinfo/announcement/c/2017-04-12/600216_20170412_9.pdf
628,2017-04-12,浙江医药董事会审计委员会2016年度履职情况报告,/disclosure/listedinfo/announcement/c/2017-04-12/600216_20170412_12.pdf
629,2017-04-12,浙江医药第七届十一次董事会决议公告,/disclosure/listedinfo/announcement/c/2017-04-12/600216_20170412_2.pdf
630,2017-04-12,浙江医药第七届十次监事会决议公告,/disclosure/listedinfo/announcement/c/2017-04-12/600216_20170412_5.pdf
631,2017-04-12,浙江医药：内部控制审计报告,/disclosure/listedinfo/announcement/c/2017-04-12/600216_20170412_11.pdf
632,2017-04-12,浙江医药：非经营性资金占用及其他关联资金往来情况的专项审计说明,/disclosure/listedinfo/announcement/c/2017-04-12/600216_20170412_8.pdf
633,2017-04-12,浙江医药：2016年度审计报告,/disclosure/listedinfo/announcement/c/2017-04-12/600216_20170412_7.pdf
634,2017-04-12,浙江医药2016年年度报告摘要,/disclosure/listedinfo/announcement/c/2017-04-12/600216_2016_nzy.pdf
635,2017-04-12,浙江医药2016年年度报告,/disclosure/listedinfo/announcement/c/2017-04-12/600216_2016_n.pdf
636,2017-04-12,浙江医药2016年度内部控制评价报告,/disclosure/listedinfo/announcement/c/2017-04-12/600216_20170412_10.pdf
637,2017-04-13,浙江医药关于续聘会计师事务所的公告,/disclosure/listedinfo/announcement/c/2017-04-13/600216_20170413_1.pdf
638,2017-04-27,浙江医药关于召开2016年年度股东大会的通知,/disclosure/listedinfo/announcement/c/2017-04-27/600216_20170427_3.pdf
639,2017-04-27,浙江医药第七届十二次董事会决议公告,/disclosure/listedinfo/announcement/c/2017-04-27/600216_20170427_2.pdf
640,2017-04-27,浙江医药2017年第一季度报告,/disclosure/listedinfo/announcement/c/2017-04-27/600216_2017_1.pdf
641,2017-05-27,浙江医药关于举行投资者接待日活动的公告,/disclosure/listedinfo/announcement/c/2017-05-27/600216_20170527_4.pdf
642,2017-05-27,浙江医药关于对全资子公司增资的公告,/disclosure/listedinfo/announcement/c/2017-05-27/600216_20170527_2.pdf
643,2017-05-27,浙江医药关于2016年年度股东大会增加临时提案的公告,/disclosure/listedinfo/announcement/c/2017-05-27/600216_20170527_3.pdf
644,2017-05-27,浙江医药第七届十三次董事会决议公告,/disclosure/listedinfo/announcement/c/2017-05-27/600216_20170527_1.pdf
645,2017-05-27,浙江医药2016年年度股东大会会议资料,/disclosure/listedinfo/announcement/c/2017-05-27/600216_20170527_5.pdf
646,2017-06-01,浙江医药关于药品申报生产获得受理的公告,/disclosure/listedinfo/announcement/c/2017-06-01/600216_20170601_1.pdf
647,2017-06-10,浙江医药2016年年度股东大会决议公告,/disclosure/listedinfo/announcement/c/2017-06-10/600216_20170610_1.pdf
648,2017-06-10,浙江医药2016年年度股东大会的法律意见书,/disclosure/listedinfo/announcement/c/2017-06-10/600216_20170610_2.pdf
649,2017-06-23,浙江医药关于控股股东增持公司股份的公告,/disclosure/listedinfo/announcement/c/2017-06-23/600216_20170623_2.pdf
650,2017-06-23,浙江医药关于控股股东部分股份质押的公告,/disclosure/listedinfo/announcement/c/2017-06-23/600216_20170623_1.pdf
651,2017-07-04,浙江医药关于控股股东增持计划实施结果的公告,/disclosure/listedinfo/announcement/c/2017-07-04/600216_20170704_1.pdf
652,2017-07-04,浙江医药关于经营范围完成工商变更登记的公告,/disclosure/listedinfo/announcement/c/2017-07-04/600216_20170704_2.pdf
653,2017-07-12,浙江医药2016年年度权益分派实施公告,/disclosure/listedinfo/announcement/c/2017-07-12/600216_20170712_1.pdf
654,2017-07-21,浙江医药关于下属企业新昌制药厂原料药通过加拿大卫生部GMP审计的公告,/disclosure/listedinfo/announcement/c/2017-07-21/600216_20170721_1.pdf
655,2017-08-08,浙江医药关于全资子公司浙江创新生物有限公司增资扩股引进战略投资者的公告,/disclosure/listedinfo/announcement/c/2017-08-08/600216_20170808_3.pdf
656,2017-08-08,浙江医药独立董事关于公司七届十四次董事会审议事项的独立意见,/disclosure/listedinfo/announcement/c/2017-08-08/600216_20170808_2.pdf
657,2017-08-08,浙江医药第七届十四次董事会决议公告,/disclosure/listedinfo/announcement/c/2017-08-08/600216_20170808_1.pdf
658,2017-08-29,浙江医药关于修改《公司章程》部分条款的公告,/disclosure/listedinfo/announcement/c/2017-08-29/600216_20170829_10.pdf
659,2017-08-29,浙江医药关于拟回购注销部分已获授但尚未解锁限制性股票的公告,/disclosure/listedinfo/announcement/c/2017-08-29/600216_20170829_7.pdf
660,2017-08-29,浙江医药关于回购注销部分限制性股票减少注册资本通知债权人的公告,/disclosure/listedinfo/announcement/c/2017-08-29/600216_20170829_9.pdf
661,2017-08-29,浙江医药关于变更会计政策的公告,/disclosure/listedinfo/announcement/c/2017-08-29/600216_20170829_6.pdf
662,2017-08-29,浙江医药公司章程（2017修订）,/disclosure/listedinfo/announcement/c/2017-08-29/600216_20170829_11.pdf
663,2017-08-29,浙江医药独立董事关于公司七届十五次董事会审议事项的独立意见,/disclosure/listedinfo/announcement/c/2017-08-29/600216_20170829_2.pdf
664,2017-08-29,浙江医药第七届十五次董事会决议公告,/disclosure/listedinfo/announcement/c/2017-08-29/600216_20170829_1.pdf
665,2017-08-29,浙江医药第七届十二次监事会决议公告,/disclosure/listedinfo/announcement/c/2017-08-29/600216_20170829_5.pdf
666,2017-08-29,浙江医药：国浩律师（上海）事务所关于浙江医药股份有限公司部分限制性股票回购注销事宜的法律意见书,/disclosure/listedinfo/announcement/c/2017-08-29/600216_20170829_8.pdf
667,2017-08-29,浙江医药2017年半年度报告摘要,/disclosure/listedinfo/announcement/c/2017-08-29/600216_2017_zzy.pdf
668,2017-08-29,浙江医药2017年半年度报告,/disclosure/listedinfo/announcement/c/2017-08-29/600216_2017_z.pdf
669,2017-09-09,浙江医药首期限制性股票激励计划预留部分激励对象名单,/disclosure/listedinfo/announcement/c/2017-09-09/600216_20170909_18.pdf
670,2017-09-09,浙江医药关于修改《公司章程》部分条款的公告,/disclosure/listedinfo/announcement/c/2017-09-09/600216_20170909_19.pdf
671,2017-09-09,浙江医药关于公司首期限制性股票激励计划预留部分授予的公告,/disclosure/listedinfo/announcement/c/2017-09-09/600216_20170909_15.pdf
672,2017-09-09,浙江医药公司章程,/disclosure/listedinfo/announcement/c/2017-09-09/600216_20170909_20.pdf
673,2017-09-09,浙江医药独立董事关于预留部分限制性股票授予事项的独立意见,/disclosure/listedinfo/announcement/c/2017-09-09/600216_20170909_13.pdf
674,2017-09-09,浙江医药独立董事关于预留部分限制性股票授予事项的独立意见,/disclosure/listedinfo/announcement/c/2017-09-09/600216_20170909_16.pdf
675,2017-09-09,浙江医药第七届十三次监事会决议公告,/disclosure/listedinfo/announcement/c/2017-09-09/600216_20170909_14.pdf
676,2017-09-09,浙江医药第七届十六次董事会决议公告,/disclosure/listedinfo/announcement/c/2017-09-09/600216_20170909_11.pdf
677,2017-09-09,浙江医药：国浩律师（上海）事务所关于浙江医药股权激励计划预留部分限制性股票授予事项之法律意见书,/disclosure/listedinfo/announcement/c/2017-09-09/600216_20170909_12.pdf
678,2017-09-09,浙江医药：国浩律师（上海）事务所关于浙江医药股权激励计划预留部分限制性股票授予事项之法律意见书,/disclosure/listedinfo/announcement/c/2017-09-09/600216_20170909_17.pdf
679,2017-09-13,浙江医药关于下属企业新昌制药厂复方蒿甲醚片获FDA批准的公告,/disclosure/listedinfo/announcement/c/2017-09-13/600216_20170913_1.pdf
680,2017-09-14,浙江医药关于下属企业新昌制药厂复方蒿甲醚片获FDA批准的补充公告,/disclosure/listedinfo/announcement/c/2017-09-14/600216_20170914_1.pdf
681,2017-10-23,浙江医药独立董事关于公司首期限制性股票激励计划首次授予限制性股票第一个解锁期解锁事项的独立意见,/disclosure/listedinfo/announcement/c/2017-10-23/600216_20171023_5.pdf
682,2017-10-23,浙江医药第七届十四次监事会决议公告,/disclosure/listedinfo/announcement/c/2017-10-23/600216_20171023_6.pdf
683,2017-10-23,浙江医药第七届十七次董事会决议公告,/disclosure/listedinfo/announcement/c/2017-10-23/600216_20171023_3.pdf
684,2017-10-23,浙江医药：国浩律师（上海）事务所关于浙江医药首期限制性股票激励计划首次授予限制性股票解锁事宜之法律意见书,/disclosure/listedinfo/announcement/c/2017-10-23/600216_20171023_4.pdf
685,2017-10-23,浙江医药2017年第三季度报告,/disclosure/listedinfo/announcement/c/2017-10-23/600216_2017_3.pdf
686,2017-10-30,浙江医药关于注销已回购部分股权激励股票的公告,/disclosure/listedinfo/announcement/c/2017-10-30/600216_20171030_1.pdf
687,2017-10-31,浙江医药关于首期限制性股票激励计划首次授予限制性股票第一个解锁期解锁暨上市的公告,/disclosure/listedinfo/announcement/c/2017-10-31/600216_20171031_1.pdf
688,2017-11-07,浙江医药关于注册资本完成工商变更登记的公告,/disclosure/listedinfo/announcement/c/2017-11-07/600216_20171107_1.pdf
689,2017-11-16,浙江医药关于美国FDA关闭公司下属企业新昌制药厂警告信的公告,/disclosure/listedinfo/announcement/c/2017-11-16/600216_20171116_1.pdf
690,2017-11-23,浙江医药关于首期限制性股票激励计划预留部分授予结果的公告,/disclosure/listedinfo/announcement/c/2017-11-23/600216_20171123_1.pdf
691,2017-11-24,浙江医药：验资报告,/disclosure/listedinfo/announcement/c/2017-11-24/600216_20171124_1.pdf
692,2017-11-30,浙江医药关于控股股东部分股份质押的公告,/disclosure/listedinfo/announcement/c/2017-11-30/600216_20171130_1.pdf
693,2017-12-07,浙江医药关于注册资本完成工商变更登记的公告,/disclosure/listedinfo/announcement/c/2017-12-07/600216_20171207_1.pdf
694,2017-12-22,浙江医药关于终止甲磺酸普喹替尼片临床试验的公告,/disclosure/listedinfo/announcement/c/2017-12-22/600216_20171222_2.pdf
695,2017-12-22,浙江医药关于获得高新技术企业认定的公告,/disclosure/listedinfo/announcement/c/2017-12-22/600216_20171222_1.pdf
696,2017-12-26,浙江医药关于控股股东部分股份解除质押的公告,/disclosure/listedinfo/announcement/c/2017-12-26/600216_20171226_1.pdf
697,2018-01-09,浙江医药关于控股子公司浙江创新生物有限公司获得保健食品生产许可证的公告,/disclosure/listedinfo/announcement/c/2018-01-09/600216_20180109_1.pdf
698,2018-01-12,浙江医药关于控股股东减持股份的公告,/disclosure/listedinfo/announcement/c/2018-01-12/600216_20180112_2.pdf
699,2018-01-23,浙江医药关于辅酶Q10产品涉诉事项美国诉讼案结案的公告,/disclosure/listedinfo/announcement/c/2018-01-23/600216_20180123_1.pdf
